Lesseliers T, Van Trappen P (November 20,
2023) Robotic Vaginal Cuff Closure During Radical Hysterectomy for Early-Stage
Cervical Cancer: The Bruges Method. Cureus 15(11): e49149. DOI
10.7759/cureus.49149
Yasnaia Bruneel, Christophe Ghysel, Caroline Van Holsbeke, Philippe Van Trappen. Fluorescence guidance during robotic resection of bladder wall endometriosis: case report and technique, Journal of Surgical Case Reports, Volume 2023, Issue 10, October 2023, rjad604. doi: 10.1093/jscr/rjad604
Van Trappen P. Robotic para-aortic sentinel lymph node mapping in endometrial, cervical, and ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 2023 Aug 10;90:102402. doi: 10.1016/j.bpobgyn.2023.102402.
Lebbe I, De Cuypere E, Claes N, Loccufier A, Ghysel C, Van Trappen P. Primary leiomyosarcoma of the uterine cervix: an unusual case and critical appraisal. J Surg Case Rep. 2023 Aug 4;2023(8):rjad439. doi: 10.1093/jscr/rjad439.
Van Trappen P, Lebbe I, De Cuypere E, Claes N. Case report: a robotic-vaginal approach for total vaginectomy and hysterectomy with pelvic sentinel lymph node dissection in primary vaginal melanoma: a 10-step technique and literature review. Front Surg. 2023 May 26;10:1189196. doi: 10.3389/fsurg.2023.1189196.
Van Trappen P, de Cuypere E, Claes N. Robotic surgery in early and advanced ovarian cancer: Case selection for surgical staging and interval debulking surgery. Eur J Obstet Gynecol Reprod Biol. 2023 Jan;280:7-11. doi: 10.1016/j.ejogrb.2022.11.005.
Van Trappen P, De Cuypere E, Claes N, Roels S. Robotic Staging of Cervical Cancer With Simultaneous Detection of Primary Pelvic and Secondary Para-Aortic Sentinel Lymph Nodes: Reproducibility in a First Case Series. Front Surg. 2022 Jun 16;9:905083. doi: 10.3389/fsurg.2022.905083. PMID: 35784928; PMCID: PMC9244622.
Van Trappen P. Indocyanine green guidance for combined robotic pelvic and para-aortic sentinel node mapping in cervical cancer. Surg Oncol. 2022 May;41:101745. doi: 10.1016/j.suronc.2022.101745. Epub 2022 Mar 26. PMID: 35358912.
Delrue C, Vanwalleghem L, Paepe P, Van Trappen P. Stratified Mucin-producing Intraepithelial Lesions of the Cervix: Clinical Diversity of Cases and Literature Review. Anticancer Res. 2022 Feb;42(2):1175-1180. doi: 10.21873/anticanres.15583. PMID: 35093923.
Dumont S, Van Trappen P. The clinical and financial impact of introducing robotic-assisted hysterectomy in a tertiary referral centre: A direct cost analysis of consecutive hysterectomies during a decade. Int J Med Robot. 2021 Oct 16:e2343. doi: 10.1002/rcs.2343. Epub ahead of print. PMID: 34655461.
de Bruyn A, Peeters F, Smulders K, Goffin F, Traen K, Van Trappen P, Vergote I. Observational BGOG Study of the Results of Robot-assisted Laparoscopy in 166 Patients with FIGO 2009 Stage IA1-IB1 Cervical Cancer. J Minim Invasive Gynecol. 2021 Nov;28(11):1920-1926. doi: 10.1016/j.jmig.2021.05.001. Epub 2021 May 14. PMID: 34000393.
Kakkos A, Ver Eecke C, Ongaro S, Traen K, Peeters F, Van Trappen P, Laenen A, Despierre E, Van Nieuwenhuysen E, Vergote I, Goffin F. Robot-assisted surgery for women with endometrial cancer: Surgical and oncologic outcomes within a Belgium gynaecological oncology group cohort. Eur J Surg Oncol. 2021 May;47(5):1117-1123. doi: 10.1016/j.ejso.2020.10.005. Epub 2020 Oct 13. PMID: 33268212.
Persyn B, Van Trappen P. Robotic Hysterectomy Using a Sealing Device: Differences In Complications and Pain Scores Between Small and Large Uteri. Surg Technol Int. 2020 Jun 10;37:sti37/1309. Online ahead of print. PMID: 32520389. https://pubmed.ncbi.nlm.nih.gov/32520389/
Vlaamse Vereniging voor Obstetrie en Gynaecologie (VVOG): “Aanbevelingen bij diagnose en behandeling van cervix carcinoom.” Ph. Van Trappen, namens de VWOG en BIG Pelviene Oncologie 2016-2019. Gunaïkeia, 2020.
Bénédicte Persyn, Philippe Van Trappen. Leverkapselruptuur bij normotensief HELLP-syndroom. Gunaïkeia Vol 24 nr 5, 2019.
Vergote I, Magrina JF, Zanagnolo V, Magtibay PM, Butler K, Gil-Moreno A, Feijoo BD, Kimmig R, Canis M, Bourdel N, Ind T, Estape R, Persson J, Lim P, Coronado P, Ponce J, Lambaudie E, Van Gorp T, Maggioni A, Narducci F, Van Niewwenhuysen E, Van Trappen P. The LACC Trial and Minimally Invasive Surgery in Cervical Cancer. J Minim Invasive Gynecol. 2020 Feb;27(2):462-463. doi: 10.1016/j.jmig.2019.09.767. Epub 2019 Sep 11.
Martin Rudnicki, Philippe van Trappen, Paul van Kesteren. Hysterectomy-Should All Residents Learn to Perform It? Editorial Acta Obstet Gynecol Scand. 2019 Jan;98(1):5-6. doi: 10.1111/aogs.13507.
Rudnicki M, Van Trappen P, van Kesteren P. Hysterectomy-Who should be trained to do it? Acta Obstet Gynecol Scand. 2019 Jun;98(6):814. doi: 10.1111/aogs.13571.
Maggen C, Van Huysse J, Van Trappen P. Simple Vaginal Trachelectomy for Small Volume Cervical Cancer: Case Report and Review of the Literature. EC Gynaecology 5.3(2017):83-90.
Neutens S, Van Trappen P. Eerste Robotgeassisteerde Fertiliteitsparende Baarmoederhalskankeroperatie in Vlaanderen. AZ Link (Sint-Jan Brugge) 35:7-9, 2017.
Coryn N, Serkei E, Weyers S, Van Trappen P. De pil Anno 2016: welke keuze en waarom? Tijdschr. voor Geneeskunde, 72, nr 18, 2016.
Hoste G, Van Trappen P. Robotic hysterectomy using the Vessel Sealer for myomatous uteri: technique and clinical outcome. Eur J Obstet Gynecol Reprod Biol. 2015 Sep 30;194:241-244.
Segaert A, Traen K, Van Trappen P, Peeters F, Leunen K, Goffin F, Vergote I. Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience. Int J Gynecol Cancer. 2015 Nov;25(9):1690-6.
Sap K, Van Trappen Ph. Paradigm shift in the management of gynaecological cancers. EMJ Oncol 2015;3:12–8.
P. Van Trappen. Centralisatie door regionalisatie van gynaecologische kankerzorg: Europees model? Gunaikeia, Vol 20;3:29-33,2015.
De Greve T, Vanwalleghem L, Van Hoof A, Coenegrachts K, Van Trappen P. An unusual cervical tumor as presentation of a non-hodgkin lymphoma. Case Rep Obstet Gynecol. 2014;2014:549619.
Mehra G, Weekes A, Vantrappen P, Visvanathan D, Jeyarajah A. Laparoscopic assisted radical vaginal hysterectomy for cervical carcinoma: morbidity and long-term follow-up. Eur J Surg Oncol. 2010 Mar;36(3):304-8.
Kruse AJ, Bottenberg MJ, Tosserams J, Slangen B, van Marion AM, van Trappen PO. The absence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to the HPV-independent pathway as the causative agent for vulvar squamous cell carcinoma and its precursor simplex VIN in a young patient. Int J Gynecol Pathol. 2008 Oct;27(4):591-5.
S Bishara, M Griffin, A Cargill, A Bali, ME Gore, SB Kaye, JH Shepherd, PO Van Trappen.Pre-treatment white blood cell subtypes as prognostic indicators in ovarian cancer. Eur J Obstet Gynecol. 138:71-75, 2008.
PO Van Trappen, B Rufford, TD Mills, SA Sohaib, JAW Webb, A Sahdev, N Ali, MJ Carroll, KE Britton, RH Reznek, IJ Jacobs. Differential diagnosis of adnexal masses: risk of malignancy index, ultrasonography, MR imaging and radioimmunoscintigraphy. Int J Gynecol Cancer, 17:61-67, 2007.
T Hagemann, T Bozanovic, S Hooper, A Ljubic, VIF Slettenaar, JL Wilson, N Singh, SA Gayther, JH Shepherd, PO Van Trappen. Molecular profiling of primary cervical cancers, lymph node micrometastases and recurrent tumours. Br J Cancer, 96: 321-328, 2007.
PO Van Trappen, T Cullup, R Troke, S Gayther, D Swann, C Mein. Somatic mitochondrial DNA mutations and polymorphisms in primary and metastatic ovarian cancer. Gynecol Oncol, 104: 129-133, 2007.
J Balega, PO Van Trappen. The sentinel lymph node in gynaecological malignancy. Cancer Imaging, 28(6): 7-15, 2006.
PO Van Trappen and MS Pepper. Lymphangiogenesis in female reproductive cancers. Angiogenesis, 8(2): 137-145, 2005.
SA Sohaib, TD Mills, A Sahdev, JA Webb, PO Van Trappen, I Jacobs and RH Reznek. The role of MRI in patients with adnexal masses identified on ultrasound. J Clin Radiol, 60: 340-348, 2005.
T. Bozanovic and PO Van Trappen. Gynaecological cancer and genetics. Cervical cancer and genetics. Gynaecology Forum, 10(1): 24-27, 2005.
A Bali, A Weekes, P Van Trappen, A Jeyarajah, D Querleu. Central pelvic recurrence seven years after radical vaginal trachelectomy. Gynecol Oncol, 96: 854-856, 2005.
PO Van Trappen, D Steele, DG Lowe, S Baithun, P Levey, N Beasley, J Krishnan, JH Shepherd, MS Pepper, D Jackson, JP Sleeman, IJ Jacobs. Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during the different stages of cervical carcinogenesis. J Pathol, 201: 544-554, 2003.
G Zhu, L Reynolds, T Crnogorac-Jurcevic, CE Gillett, EA Dublin, JF Marshall, D Barnes, C D’Arrigo, PO Van Trappen, NR Lemoine and IR Hart. Combination Of Microdissection And Microarray Analysis To Identify Gene Expression Changes Between Differentially Located Tumor Cells In Breast Cancer. Oncogene, 22: 3742-3748, 2003.
SAA Sohaib, A Sahdev, PO Van Trappen, I Jacobs, RH Reznek. Characterisation of adnexal mass lesions on magnetic resonance imaging. Am J Radiol, 180: 1297-1304, 2003.
EC Kohn, IJ Fidler, D Fishman, R Jaffe, LA Liotta, P Van Trappen, GB Mills, C Trope. Discussion: Metastasis and angiogenesis in epithelial ovarian cancer. Gynecol Oncol, 88: S37-S42, 2003.
N Ali, H Jan, PO Van Trappen, F Nasreen, A Canizales, MJ Carroll, M Granowska, IJ Jacobs, KE Britton. Tc-99m SM3 radioimmunoscintigraphy (RIS) and its distinction between malignant and benign adnexal masses. Br J Obstet Gynaecol, 110: 508-514, 2003.
PO Van Trappen and MS Pepper. Lymphatic dissemination of tumour cells and the formation of tumour micrometastases. Lancet Oncol, 3: 44-52, 2002.
Beasley NJP, Prevo R, Banerji S, Leek R, Moore J, Van Trappen PO, Cox G, Harris AL, Jackson DG. Intratumoural lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res, 62: 1315-1320, 2002.
PO Van Trappen, A Ryan, M Carroll, C Lecoeur, L Goff, V Gyselman, B Young, D Lowe, MS Pepper, JH Shepherd, I Jacobs. A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer. Br J Cancer, 87: 537-544, 2002.
Van Trappen PO, Gyselman VG, Lowe DG, Ryan A, Oram DH, Bosze P, Weekes AR, Shepherd JH, Dorudi S, Bustin SA, Jacobs IJ. Molecular quantification and mapping of lymph node micrometastases in cervical cancer. The Lancet, 357: 15-20, 2001.
PO Van Trappen, MS Pepper. Lymphangiogenesis and lymph node microdissemination. Gynecol Oncol, 82: 1-3, 2001.
P. Van Trappen, R. Serreyn, A. E. Elewaut, V. Cocquyt, S. Van Belle. Abdominal pain with anorexia in patients with breast carcinoma. Ann Oncol, 9: 1243-1245, 1998.
P. Van Trappen. Screening and Diagnosis of Gynaecological Cancers: pre-operative assessment of the adnexal mass. The Diplomate (RCOG), 5(3): 208-214, 1998.
P. Van Trappen, K. Verbeken, M. Temmerman. Pre-eclampsia and chromosomal anomalies. J Obstet Gynaecol, 18(6): 550-552, 1998.
P. Van Trappen, P. De Sutter, M. Dhont. Vaginoplasty by inverted perineal and labia minora flaps – a retrospective study. J Obstet Gynaecol, 17(4): 379-382, 1997.
I. Buytaert, A. Elewaut, P. Van Trappen. Liver diseases in pregnancy. Belgian J Medecine, 52 (3): 213-216, 1996.
P. Van Trappen, R. Serreyn, C. De Potter. Estrogen receptor incidence in ductal carcinoma in-situ: estimated benefit following anti-estrogen therapy. Acta Clinica Belgica, 51(3): 205, 1996.
P. Van Trappen, R. Van den Broecke, H. Depypere, C. De Potter, R. Serreyn. Histopathology of microcalcifications in the breast and immunohistochemistry of ductal carcinoma in-situ lesions. Acta Clinica Belgica, 51(3): 207, 1996.
F.M. Belpaire, P. Wynant, P. Van Trappen, M. Dhont, A. Verstraete, M.G. Bogaert. Protein binding of propranolol and verapamil enantiomers in maternal and foetal serum. Br J Clin. Pharmac, 39: 190-193, 1995.
Hoofdstukken
PO Van Trappen, I Jacobs. Controversies and new trends in staging ovarian and fallopian tube carcinoma. Chapter 20. CME J Gynecol Oncol. 6: 260-266, 2001.
PO Van Trappen and IJ Jacobs. The genetics and molecular biology of gynaecological cancer. Gynaecology, Chapter 36: 527-543. Editors: R Shaw, WP Soutter, SL Stanton, 3rd Edition, 2003.
CD-ROM
Van Trappen P. Real-time quantitative reverse transcriptase-polymerase chain reaction for the detection of occult micrometastases in cervical cancer patients. Interactive CD-ROM of Gynaecological Oncology with 40 selected international speakers, IGCS, 1999.
24/11/2023: Invited Lecture on “Use of advanced energy in gynaecological oncology: malignant hysterectomy” at the 13th Annual Conference of the British and Irish Association of Robotic Gynaecological Surgeons, London.
21/10/2023: Invited Video-guided Lecture “Robotic-vaginal en bloc hysterectomy and total vaginectomy for early-stage vaginal melanoma” at the 2nd Annual Congress of the Society of Korean Robot Gynecologic Surgery, South-Korea.
04/10/2023: Invited Lecture “How to perform a successful Robotic Radical Hysterectomy for cervical cancer” at the European Society of Gynaecological Endoscopy (ESGE) Congress, Brussels.
03/10/2023: Organizer and Moderator Live Robotic Surgery at AZ Sint-Jan Hospital Bruges, robotic myomectomy and robotic sacrocolpopexy, for the European Society of Gynaecological Endoscopy (ESGE) Congress in Brussels.
09/06/2023: “Robotic para-aortic staging: who is eligible?” at the Society of European Robotic Gynaecological Surgeons (SERGS) in Athens
16/12/2022: Live Robotic GYN Surgery 4Health – Worldwide Robotic Surgery Events (WRSE12) –
16th December 2022 – International Faculty member – Semi-Live robotic surgery:
Video-recorded surgery
12/11/2022:
Hamburg Intensiv Seminar GYN-ONKO (1200 participants) – 12th November 2022 –
Lecture: “Robotic surgery in Gynecological Oncology: present and future”.
29/10/2022:
European Society of Gynecological Oncology (ESGO) Conference – Berlin – 29th
October Satellite Symposium Intuitive – Lecture: “Use of advanced energy in
pelvic and paraaortic lymph node dissection”.
3/10/2022:
European Society of Gynecological Endoscopy (ESGE) Conference – Lisbon – 3rd
October Satellite Symposium Intuitive – “Meet the professors” session: Lecture
“The value of da Vinci technology in endometrial cancer surgery”.
11/05/2022:
GYN CONNECT Robotics Forum Intuitive – Paris – 11th May 2022 – Lecturer.
6-8/4/2022:
Advanced Course in Robotic Gynaecological Oncology Surgery – joint ESGO-SERGS
(Society of European Robotic Gynecological Surgeons) course – ORSI Belgium –
6-8 April 2022. Master Proctor and Lecturer.
16-17/3/2022:
Peer-to-Peer Master Proctors Robotic Surgery – GYN Summit Intuitive Surgical –
IRCAD Strasbourg – 16-17 March 2022: Lecturer to Peers.
19/10/2021: Webinar European Society for Robotic Gynaecological Surgery (SERGS) – presentation “Robotic complex benign hysterectomy”, P. Van Trappen.
10/06/2021: Gyn Connect Up – International Forum (Intuitive Surgical Inc): presentation “Use of advanced robotic technologies for malignant procedures”, P. Van Trappen
17/3/2020: 1st Webinar SERGS: “Robotic vs Laparoscopic Surgery in Endometriosis”. P. Van Trappen.
7/02/2020: Voordracht voor de Wetenschappelijke Vereniging voor Verzekeringsgeneeskunde (WVV) aan Universiteit Antwerpen: “Chirurg en Robot: een nieuw onafscheidelijk duo”.
26-28/9/2019: 11th Annual SERGS (European Society of Robotic Gynaecological Surgery) meeting in Sofia (Bulgaria): Chairing the session on “Benign Robotic Surgery”; Panel member + presentation on “Endometriosis and Robotics”.
26-28/6/2019: Secondary Advanced Robotic Surgery Course in Gynaecological Oncology – Ghent (Melle) organised by ESGO-SERGS/Faculty members: T. Hebert (France), H. Falconer (Sweden), E. Lambaudie (France), P. Van Trappen (Belgium).
10-11/4/2019: Master Class + Live Surgery voor Robot chirurgie te Berlijn: “Robotic Surgery in Cervical Cancer”– Vivantes Klinikum – Berlin
11 mei 2019: Nationaal congres “Medische Wereld” te Brussel – VUB: “Medisch expert – Fonds voor Medische Ongevallen: efficiënte interactie?”
18 en 19 april 2018: Master Class + Live Surgery voor Robot chirurgie te Berlijn: “Robotic Surgery in Cervical Cancer” – Vivantes Klinikum – Berlin
VVOG congres 04/10/2018 te Mechelen: “Lokaal gevorderd cervix carcinoom”
27-28/09/2018 10th Annual SERGS meeting: Chairing Robot Benigne Gynaecology; Voordracht: Robotic surgery in large uterus
Voorzitter/organisator: Cursus Pelviene Oncologie voor assistenten VVOG, Gent, 20 oktober 2017.
Master Class Chirurgie Robotique, invited speaker: “Place des technologies avancées en chirurgie robotique”. Rennes (Bretagne), France, 13-14 oktober 2017.
Robot chirurgie in gynaecologische oncologie. Oncologie Symposium, De Valckaert, Oostkamp, 11 februari 2017.
Surgical Video day: Robotic radical hysterectomy and Robotic Para-aortic lymph node dissection. 7th Annual British and Irish Association of Robotic Gynaecological Surgeons (BIARGS), University of Leicester (UK), 1-3 maart 2017.
Robotic hysterectomy for a large uterus. 7th Annual British and Irish Association of Robotic Gynaecological Surgeons (BIARGS), University of Leicester (UK), 1-3 maart 2017.
Paradigm shift from laparoscopic to robotic surgery. 7th Annual British and Irish Association of Robotic Gynaecological Surgeons (BIARGS), University of Leicester (UK), 1-3 maart 2017.
Robot chirurgie in gynaecologie/oncologie. Navormingscursus operatieverpleegkundigen, VIVES Hogeschool, Brugge, 7 maart 2017.
Nieuwe Technieken voor behandeling van gynaecologische kankers. Vereniging “Actueel denken en leven”, Kinepolis Brugge, 1 maart 2016.
Robotic Devices – Video debate. 8th Annual Meeting on Robotic Gynaecological Surgery (SERGS), Barcelona (Spanje), 16-18 juni 2016.
Step-by-step Large Uterus Hysterectomy. 8th Annual Meeting on Robotic Gynaecological Surgery (SERGS), Barcelona (Spanje), 16-18 juni 2016.
Robotic surgery in Gynaecology/oncology in Bruges. ESM Intuitive Surgical, Barcelona (Spanje), 25 augustus 2016.
Chairman “New Frontiers in Gynaecological Cancer Management”, Gynaecologisch Oncologisch symposium, Concertgebouw Brugge, 1 oktober 2016.
“Ultra-radical surgery for ovarian cancer” at Royal Marsden Symposium on Surgical Aspects of Ovarian Cancer in London, 9 december 2011, Engeland.
“Bipolar Vessel Sealing Device in Gynaecologische/Oncologische Chirurgie”, voor de Apothekersvereniging van oost-en West-Vlaanderen, 20 oktober 2011, De Pinte, België.
“Endoscopic versus open surgery in endometrial cancer: outcomes” at International Symposium of Gynaecologic Surgery: from benign to cancer – State of the art, Cefalu (Sicily), 27 mei 2011, Italië.
“Primaire en intervaldebulkingchirurgie bij ovariumcarcinoom: state-of-the-art. KHBO Permanante vorming ‘Operatieverpleegkunde’. Brugge, 22 februari 2011.
“Gynaecologische Oncologische Chirurgie: de grenzen verleggen”. AZ Colloquia St.-Jan Brugge. 21 december 2010 en Permanente vorming 2011 Verpleegkundigen heelkunde – operatiekwartier – campus Brugge, 5 apil 2011.
“Chirurgie van vergevorderd ovarium carcinoom”. LOK 0317 – WGSV in Zeeland, 25 september 2010.
“Nieuwe perspectieven in de gynaecologische oncologie”. Voordracht voor artsengroep “Houtland” te Torhout, 14 oktober 2010.
“Surgical treatment of ovarian cancer” at regional doctors meeting Stockholm-Gotland, at Elite Palace Hotel, Stockholm (Sweden) 11 december 2009.
“Surgical treatment of Breast Cancer: what … and why”. Breast Cancer Symposium (Breast Clinic: FAQ) at ’t Pand Ghent, from AZ Jan Palfijn Hospital Ghent, Belgium, 25 April 2009.
“Gynaecologische tumoren: internationale richtlijnen en nieuwe perspectieven.”. Symposium Oncologie – AZ Jan Palfijn 7 juni 2008.
“Technics en Genetics bij cervix, ovarium en mammacarcinoom”. HAVRA huisartsengroep, Aalter, 31 januari 2008, België.
“Vaccinatie ter preventie van het cervix carcinoom”, Randwijck cursus, azM, Maastricht, 27 maart 2007, Nederland.
“De toegevoegde waarde van MRI in de risk of malignancy index. Keynote Lecture voor de gynaecologische oncologie op Doelen Congres Obstetrie/Gynaecologie & Infertiliteit te Rotterdam, 19 april 2007, Nederland.
“Oncologische chirurgie en Robot chirurgie in de gynaecologie”. Lok vergadering Aalst, 30 oktober 2007, België.
“Technics en Genetics bij cervix, ovarium en mammacarcinoom”. Huisartsenvereniging Hippoliet van Peene, Eeklo, 8 november 2007, België.
“Laparoscopie in de gynaecologische oncologie”, Veldhoven refereeravond, 14 november 2006, Nederland.
“From bench to bedside in gynaecological oncology”. VVOG, Overijse (Belgium), 1st October 2005, België.
“Management of early-stage cervical cancer”. North-East Thames specialist registrars meeting. Lecture at The Royal London Hospital, on the 9th January 2004, Engeland.
“Lymphangiogenesis and lymph node metastases”. 13th Meeting of the European Society of Gynaecological Oncology, Brussels, 8th April 2003, België.
“Molecular events in cervical cancer”. University Charles of Prague. Department of Obstetrics & Gynaecology (Prof. Lukas Rob), 19th May 2004, Prague, Czech Republic.
“Progress in Gynaecological Cancer Research”, Karolinska Institute – Stockholm, Sweden. Department of Gynaecological Oncology (Prof. E.A. Lundquist), on 14th June 2004, Zweden.
“Molecular Determinants of Cervical Cancer Progression”. 7th International Conference on Anti-cancer Research. Corfu, Greece. 25-30 October 2004, Griekenland.
“Cervical Cancer Screening”. Joint London course in Oncology. Lecture at Royal College of Radiologists, on the 11th December 2003, Engeland.
“Angiogenesis and Lymphangiogenesis in Gynaecological Cancers”. Dutch Society of Gynaecological Oncology/COBRA; “Metastatic tumours and recurrences”. Utrecht, 12-13th December 2002, Nederland.
“Ovarian Cancer Screening”. Lecture for registrars in Medical Oncology London, Royal College of Radiologists, 9th January 2002, Engeland.
“Assessing malignant potential of an adnexal mass”. North-East Thames Gynaecology Meeting, University College Hospital, London, 14th June 2002, Engeland.
“Management of early-stage cervical cancer”. North-East Thames trainees in Obstetrics and Gynaecology, Royal London Hospital, London, 22 November 2002, Engeland.
“Novel molecular diagnostic approaches to identify genetic events in ovarian cancer”. Free University Amsterdam, 29 March, 2001, Nederland.
“Metastasis and Angiogenesis”. Panel member. Helene Harris Memorial Trust: 8th Biennial International Forum on ovarian cancer. MD Anderson Cancer Centre, Houston, USA, 20 March 2001, United States.
“Molecular diagnosis and staging”. Annual British Gynaecological Cancer Society Meeting, London, 14 November 2001, Engeland.
“Molecular Technology in Gynaecological Cancer”. Chairman of workshop. Annual British Gynaecological Cancer Society Meeting, London, 15 November 2001, Engeland.
“Molecular events in angiogenesis/lymphangiogenesis”. ICRF Medical Oncology Seminars, London, 31 January 2001, Engeland.
“Detection of micrometastases by means of molecular biology”. University of Innsbruck (Prof. Ch. Marth), Austria, January 2000, Oostenrijk.
“Molecular Staging in Cervical Cancer”. The VIII Meeting of the International Gynaecologic Cancer Society at Buenos Aires (Argentina), October 22-26, 2000, Argentinië.
“Novel Diagnostic Approaches to Cervical and Ovarian Cancer”. Workshop: “Molecular Biology: any good news?” Buenos Aires (Argentina), October 26, 2000, Argentinië.
“Angiogenesis and Micrometastases in Cervical Cancer”. Grand Round, Barts and the London NHS Trust, March 7, 2000, Engeland.
“Imaging of an adnexal mass”. Academic meeting of Obstetrics and Gynaecology, London, April 14, 2000, Engeland.
“Molecular quantification of micrometastases”. 1st workshop in molecular genetics of cancer, St. Bartholomew’s Hospital, London, May 30, 2000, Engeland.
“Tumour Angiogenesis and Micrometastasis”, Research Scientist Forum, Queen Mary and Westfield College, London, 3rd October, 2000, Engeland.
“The genetics of angiogenesis – A computer based 3D model”. William Harvey Day, Queen Mary University London, 17 October 2000, London, Engeland.
“Molecular staging of cervical cancer using real-time RT-PCR: correlation between number of cancer cells in normal lymph nodes and prognostic features”. The 31st Society of Gynaecologic Oncology Meeting, San Diego, USA, February 4-8, 2000, United States.
“Molecular profiling of angiogenesis and occult micrometastases in cervical cancer”. The British Cancer Research Meeting, Brighton, July 10-12, 2000, Engeland.
“Molecular Staging in Cervical Cancer”. The VIII Meeting of the International Gynecologic Cancer Society at Buenos Aires (Argentina), October 22-26, 2000, Argentinië.
“Tumour Markers, MRI, Radioimmunoscintigraphy, ultrasound and doppler in the differential diagnosis of benign and malignant adnexal masses”. Academic meeting of Gynaecological Oncology, January 8, 1999, Royal London Hospital, Engeland.
“Molecular Staging of Gynaecological Cancer”. Association of North Thames (East) Obstetricians & Gynaecologists, Annual Meeting London, November 19, 1999, Engeland.
“Molecular detection of submicroscopic disease”. Oncology Workshop, Erlangen University, Germany, November 1999, Duitsland.
“Molecular detection of metastatic disease in gynaecological cancer using quantitative RT-PCR for cytokeratin 19”. Selected for oral presentation at the 11th International Meeting of the European Society of Gynaecological Oncology at Budapest (Hungary), 8-12 May 1999, Hongarije.
“Real-time quantitative reverse transcriptase-polymerase chain reaction for the detection of occult micrometastases in cervical cancer patients”. Selected for oral presentation at the 7th Biennial Meeting of the International Gynaecologic Cancer Society at Vatican City (Italy), September 26-30, 1999 and at the Beatson International Cancer Conference “Invasion and Metastasis”, Glasgow, June 26-29, 1999, Schotland.
“Molecular staging in cervical cancer using real-time quantitative RT-PCR: how many cancer cells in the lymph nodes are needed to become clinically significant”. The British Gynaecological Cancer Society meeting in London, November, 1999, Engeland.
“Cytoskeletal aberrations as predictors of invasion in gynaecological cancers”. Royal London Hospital on 29th April 1998 (Queen Mary and Westfield College), London, Engeland.
“Haptoglobin-phenotype: incidentie en klinisch verloop van preeclampsie”. Internationaal Symposium van de NVOG en de VVOG, 1997, Nederland.
“Resultaten van de Bhonsale – vaginoplasty: een retrospectieve studie”. Jaarlijkse vergadering van de Vereniging voor Fertiliteitsstudie van Vlaanderen en Nederland, Corsendonck, 1996, België.
“Estrogen receptor incidence in ductal carcinoma in-situ: estimated benefit following anti-estrogen therapy”. Scientific meeting of the Belgian Association for Cancer Research, 1996: Breast Cancer – Advances and controversies, België.
“Suspicious microcalcifications in the breast: correlation with histopathology”. Advanced course of Breast Cancer, at the European School of Oncology, Milan, Italy, 1995, Italië.
“Endometriose van de blaas”. Nationaal Kongres van de Koninklijke Belgische Vereniging voor Gynaecologie en Verloskunde, Brussel, 1994, België.
“Acute leversteatose in de zwangerschap”. Nationaal Kongres van de Koninklijke Belgische Vereniging voor Gynaecologie en Verloskunde, Brussel, 1993, België.
2022-heden Academic Committee Member Society of European Robotic Gynaecological Surgeons (SERGS)
2017-2021 Council Member Society of European Robotic Gynaecological Surgeons (SERGS)
2016-2019 Voorzitter BIG Pelviene Oncologie VVOG (Pelvic Oncology Group Flemish Organisation VVOG)
2013-2016 Secretaris werkgroep gynaecologische oncologie VVOG
2010-heden Gynaecoloog/Oncoloog en Diensthoofd Gynaecologie/Oncologie AZ Sint-Jan Brugge AV, België
2009-2010 Senior Consultant (Overläkare) Surgeon Gynaecologie/Oncologie in Karolinska University Hospital, Stockholm, Zweden
2007-2009 Gynaecoloog/Oncoloog in AZ Jan Palfijn Ziekenhuis Gent, coördinatie Gynaecologisch Oncologisch Centrum en Borstkliniek, België
2006-2007 Gewoon Hoogleraar (Professor) en Hoofd Gynaecologie & Gynaecologische Oncologie, Academisch Ziekenhuis Maastricht, Nederland
2005-2006 Consultant en Clinical Senior Lecturer (Associate-Professor) Gynaecologische Oncologie, Gynaecological Cancer Centre, St. Bartholomew’s Hospital, London, Engeland
2001-2004 Senior Fellow Gynaecologische Oncologie (“Royal College of Obstetricians and Gynaecologists”), St. Bartholomew’s Hospital & The Royal Marsden Hospital – London (Prof. John Shepherd and Prof. Ian Jacobs); Fellow darmchirurgie, Royal London Hospital (Prof. Sina Dorudi) & Old Church Hospital (Romford; Mr. Clive Hepworth), Engeland
2002-2004 Cancer Research UK Clinician Scientist, Translational Oncology Laboratory, St. Bartholomew’s Hospital, London, Engeland
1998-2001 Clinical Research Fellow (PhD), Gynaecological Oncology Unit (Prof. Ian Jacobs), St. Bartholomew’s Hospital, London, Engeland
1992-1997 Specialist in opleiding in Verloskunde, Gynaecologie en Infertiliteit, Universitair Ziekenhuis Gent, België en St. Elisabeth Ziekenhuis Tilburg, Nederland
1990-1991 Vertegenwoordiger medische studenten België voor het “Erasmus project”
1989-1990 Praeses medische studentenorganisatie Gent (VKG), België
1988-1989 Vice-Praeses medische studentenorganisatie Gent (VKG), België
2015-heden European Society of European Robotic Gynaecological Surgeons (SERGS)
1999-heden European Society of Gynaecological Oncology (ESGO)
2006-heden International Gynaecological Cancer Society (IGCS)
1997-heden Vlaamse Vereniging voor Obstetrie en Gynaecologie (VVOG)
2005-heden Faculty Member of Faculty of 1000 Medicine: Gynaecological Cancer Group
http://www.f1000medicine.com
2010-heden Academia: independent.academia.edu/PhilippeVanTrappen
Yasnaia Bruneel, Christophe Ghysel, Caroline Van Holsbeke, Philippe Van Trappen. Fluorescence guidance during robotic resection of bladder wall endometriosis: case report and technique, Journal of Surgical Case Reports, Volume 2023, Issue 10, October 2023, rjad604. doi: 10.1093/jscr/rjad604
Lesseliers T, Van Trappen P (November 20, 2023) Robotic Vaginal Cuff Closure During Radical Hysterectomy for Early-Stage Cervical Cancer: The Bruges Method. Cureus 15(11): e49149. DOI 10.7759/cureus.49149
Van Trappen P. Robotic para-aortic sentinel lymph node mapping in endometrial, cervical, and ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 2023 Aug 10;90:102402. doi: 10.1016/j.bpobgyn.2023.102402.
Lebbe I, De Cuypere E, Claes N, Loccufier A, Ghysel C, Van Trappen P. Primary leiomyosarcoma of the uterine cervix: an unusual case and critical appraisal. J Surg Case Rep. 2023 Aug 4;2023(8):rjad439. doi: 10.1093/jscr/rjad439.
Van Trappen P, Lebbe I, De Cuypere E, Claes N. Case report: a robotic-vaginal approach for total vaginectomy and hysterectomy with pelvic sentinel lymph node dissection in primary vaginal melanoma: a 10-step technique and literature review. Front Surg. 2023 May 26;10:1189196. doi: 10.3389/fsurg.2023.1189196.
Van Trappen P, de Cuypere E, Claes N. Robotic surgery in early and advanced ovarian cancer: Case selection for surgical staging and interval debulking surgery. Eur J Obstet Gynecol Reprod Biol. 2023 Jan;280:7-11. doi: 10.1016/j.ejogrb.2022.11.005.
Van Trappen P, De Cuypere E, Claes N, Roels S. Robotic Staging of Cervical Cancer With Simultaneous Detection of Primary Pelvic and Secondary Para-Aortic Sentinel Lymph Nodes: Reproducibility in a First Case Series. Front Surg. 2022 Jun 16;9:905083. doi: 10.3389/fsurg.2022.905083. PMID: 35784928; PMCID: PMC9244622.
Van Trappen P. Indocyanine green guidance for combined robotic pelvic and para-aortic sentinel node mapping in cervical cancer. Surg Oncol. 2022 May;41:101745. doi: 10.1016/j.suronc.2022.101745. Epub 2022 Mar 26. PMID: 35358912.
Delrue C, Vanwalleghem L, Paepe P, Van Trappen P. Stratified Mucin-producing Intraepithelial Lesions of the Cervix: Clinical Diversity of Cases and Literature Review. Anticancer Res. 2022 Feb;42(2):1175-1180. doi: 10.21873/anticanres.15583. PMID: 35093923.
Dumont S, Van Trappen P. The clinical and financial impact of introducing robotic-assisted hysterectomy in a tertiary referral centre: A direct cost analysis of consecutive hysterectomies during a decade. Int J Med Robot. 2021 Oct 16:e2343. doi: 10.1002/rcs.2343. Epub ahead of print. PMID: 34655461.
de Bruyn A, Peeters F, Smulders K, Goffin F, Traen K, Van Trappen P, Vergote I. Observational BGOG Study of the Results of Robot-assisted Laparoscopy in 166 Patients with FIGO 2009 Stage IA1-IB1 Cervical Cancer. J Minim Invasive Gynecol. 2021 Nov;28(11):1920-1926. doi: 10.1016/j.jmig.2021.05.001. Epub 2021 May 14. PMID: 34000393.
Kakkos A, Ver Eecke C, Ongaro S, Traen K, Peeters F, Van Trappen P, Laenen A, Despierre E, Van Nieuwenhuysen E, Vergote I, Goffin F. Robot-assisted surgery for women with endometrial cancer: Surgical and oncologic outcomes within a Belgium gynaecological oncology group cohort. Eur J Surg Oncol. 2021 May;47(5):1117-1123. doi: 10.1016/j.ejso.2020.10.005. Epub 2020 Oct 13. PMID: 33268212.
Persyn B, Van Trappen P. Robotic Hysterectomy Using a Sealing Device: Differences In Complications and Pain Scores Between Small and Large Uteri. Surg Technol Int. 2020 Jun 10;37:sti37/1309. Online ahead of print. PMID: 32520389. https://pubmed.ncbi.nlm.nih.gov/32520389/
Vlaamse Vereniging voor Obstetrie en Gynaecologie (VVOG): “Aanbevelingen bij diagnose en behandeling van cervix carcinoom.” Ph. Van Trappen, namens de VWOG en BIG Pelviene Oncologie 2016-2019. Gunaïkeia, 2020.
Bénédicte Persyn, Philippe Van Trappen. Leverkapselruptuur bij normotensief HELLP-syndroom. Gunaïkeia Vol 24 nr 5, 2019.
Vergote I, Magrina JF, Zanagnolo V, Magtibay PM, Butler K, Gil-Moreno A, Feijoo BD, Kimmig R, Canis M, Bourdel N, Ind T, Estape R, Persson J, Lim P, Coronado P, Ponce J, Lambaudie E, Van Gorp T, Maggioni A, Narducci F, Van Niewwenhuysen E, Van Trappen P. The LACC Trial and Minimally Invasive Surgery in Cervical Cancer. J Minim Invasive Gynecol. 2020 Feb;27(2):462-463. doi: 10.1016/j.jmig.2019.09.767. Epub 2019 Sep 11.
Martin Rudnicki, Philippe van Trappen, Paul van Kesteren. Hysterectomy-Should All Residents Learn to Perform It? Editorial Acta Obstet Gynecol Scand. 2019 Jan;98(1):5-6. doi: 10.1111/aogs.13507.
Rudnicki M, Van Trappen P, van Kesteren P. Hysterectomy-Who should be trained to do it? Acta Obstet Gynecol Scand. 2019 Jun;98(6):814. doi: 10.1111/aogs.13571.
Maggen C, Van Huysse J, Van Trappen P. Simple Vaginal Trachelectomy for Small Volume Cervical Cancer: Case Report and Review of the Literature. EC Gynaecology 5.3(2017):83-90.
Neutens S, Van Trappen P. Eerste Robotgeassisteerde Fertiliteitsparende Baarmoederhalskankeroperatie in Vlaanderen. AZ Link (Sint-Jan Brugge) 35:7-9, 2017.
Coryn N, Serkei E, Weyers S, Van Trappen P. De pil Anno 2016: welke keuze en waarom? Tijdschr. voor Geneeskunde, 72, nr 18, 2016.
Hoste G, Van Trappen P. Robotic hysterectomy using the Vessel Sealer for myomatous uteri: technique and clinical outcome. Eur J Obstet Gynecol Reprod Biol. 2015 Sep 30;194:241-244.
Segaert A, Traen K, Van Trappen P, Peeters F, Leunen K, Goffin F, Vergote I. Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience. Int J Gynecol Cancer. 2015 Nov;25(9):1690-6.
Sap K, Van Trappen Ph. Paradigm shift in the management of gynaecological cancers. EMJ Oncol 2015;3:12–8.
P. Van Trappen. Centralisatie door regionalisatie van gynaecologische kankerzorg: Europees model? Gunaikeia, Vol 20;3:29-33,2015.
De Greve T, Vanwalleghem L, Van Hoof A, Coenegrachts K, Van Trappen P. An unusual cervical tumor as presentation of a non-hodgkin lymphoma. Case Rep Obstet Gynecol. 2014;2014:549619.
Mehra G, Weekes A, Vantrappen P, Visvanathan D, Jeyarajah A. Laparoscopic assisted radical vaginal hysterectomy for cervical carcinoma: morbidity and long-term follow-up. Eur J Surg Oncol. 2010 Mar;36(3):304-8.
Kruse AJ, Bottenberg MJ, Tosserams J, Slangen B, van Marion AM, van Trappen PO. The absence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to the HPV-independent pathway as the causative agent for vulvar squamous cell carcinoma and its precursor simplex VIN in a young patient. Int J Gynecol Pathol. 2008 Oct;27(4):591-5.
S Bishara, M Griffin, A Cargill, A Bali, ME Gore, SB Kaye, JH Shepherd, PO Van Trappen.Pre-treatment white blood cell subtypes as prognostic indicators in ovarian cancer. Eur J Obstet Gynecol. 138:71-75, 2008.
PO Van Trappen, B Rufford, TD Mills, SA Sohaib, JAW Webb, A Sahdev, N Ali, MJ Carroll, KE Britton, RH Reznek, IJ Jacobs. Differential diagnosis of adnexal masses: risk of malignancy index, ultrasonography, MR imaging and radioimmunoscintigraphy. Int J Gynecol Cancer, 17:61-67, 2007.
T Hagemann, T Bozanovic, S Hooper, A Ljubic, VIF Slettenaar, JL Wilson, N Singh, SA Gayther, JH Shepherd, PO Van Trappen. Molecular profiling of primary cervical cancers, lymph node micrometastases and recurrent tumours. Br J Cancer, 96: 321-328, 2007.
PO Van Trappen, T Cullup, R Troke, S Gayther, D Swann, C Mein. Somatic mitochondrial DNA mutations and polymorphisms in primary and metastatic ovarian cancer. Gynecol Oncol, 104: 129-133, 2007.
J Balega, PO Van Trappen. The sentinel lymph node in gynaecological malignancy. Cancer Imaging, 28(6): 7-15, 2006.
PO Van Trappen and MS Pepper. Lymphangiogenesis in female reproductive cancers. Angiogenesis, 8(2): 137-145, 2005.
SA Sohaib, TD Mills, A Sahdev, JA Webb, PO Van Trappen, I Jacobs and RH Reznek. The role of MRI in patients with adnexal masses identified on ultrasound. J Clin Radiol, 60: 340-348, 2005.
T. Bozanovic and PO Van Trappen. Gynaecological cancer and genetics. Cervical cancer and genetics. Gynaecology Forum, 10(1): 24-27, 2005.
A Bali, A Weekes, P Van Trappen, A Jeyarajah, D Querleu. Central pelvic recurrence seven years after radical vaginal trachelectomy. Gynecol Oncol, 96: 854-856, 2005.
PO Van Trappen, D Steele, DG Lowe, S Baithun, P Levey, N Beasley, J Krishnan, JH Shepherd, MS Pepper, D Jackson, JP Sleeman, IJ Jacobs. Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during the different stages of cervical carcinogenesis. J Pathol, 201: 544-554, 2003.
G Zhu, L Reynolds, T Crnogorac-Jurcevic, CE Gillett, EA Dublin, JF Marshall, D Barnes, C D’Arrigo, PO Van Trappen, NR Lemoine and IR Hart. Combination Of Microdissection And Microarray Analysis To Identify Gene Expression Changes Between Differentially Located Tumor Cells In Breast Cancer. Oncogene, 22: 3742-3748, 2003.
SAA Sohaib, A Sahdev, PO Van Trappen, I Jacobs, RH Reznek. Characterisation of adnexal mass lesions on magnetic resonance imaging. Am J Radiol, 180: 1297-1304, 2003.
EC Kohn, IJ Fidler, D Fishman, R Jaffe, LA Liotta, P Van Trappen, GB Mills, C Trope. Discussion: Metastasis and angiogenesis in epithelial ovarian cancer. Gynecol Oncol, 88: S37-S42, 2003.
N Ali, H Jan, PO Van Trappen, F Nasreen, A Canizales, MJ Carroll, M Granowska, IJ Jacobs, KE Britton. Tc-99m SM3 radioimmunoscintigraphy (RIS) and its distinction between malignant and benign adnexal masses. Br J Obstet Gynaecol, 110: 508-514, 2003.
PO Van Trappen and MS Pepper. Lymphatic dissemination of tumour cells and the formation of tumour micrometastases. Lancet Oncol, 3: 44-52, 2002.
Beasley NJP, Prevo R, Banerji S, Leek R, Moore J, Van Trappen PO, Cox G, Harris AL, Jackson DG. Intratumoural lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res, 62: 1315-1320, 2002.
PO Van Trappen, A Ryan, M Carroll, C Lecoeur, L Goff, V Gyselman, B Young, D Lowe, MS Pepper, JH Shepherd, I Jacobs. A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer. Br J Cancer, 87: 537-544, 2002.
Van Trappen PO, Gyselman VG, Lowe DG, Ryan A, Oram DH, Bosze P, Weekes AR, Shepherd JH, Dorudi S, Bustin SA, Jacobs IJ. Molecular quantification and mapping of lymph node micrometastases in cervical cancer. The Lancet, 357: 15-20, 2001.
PO Van Trappen, MS Pepper. Lymphangiogenesis and lymph node microdissemination. Gynecol Oncol, 82: 1-3, 2001.
P. Van Trappen, R. Serreyn, A. E. Elewaut, V. Cocquyt, S. Van Belle. Abdominal pain with anorexia in patients with breast carcinoma. Ann Oncol, 9: 1243-1245, 1998.
P. Van Trappen. Screening and Diagnosis of Gynaecological Cancers: pre-operative assessment of the adnexal mass. The Diplomate (RCOG), 5(3): 208-214, 1998.
P. Van Trappen, K. Verbeken, M. Temmerman. Pre-eclampsia and chromosomal anomalies. J Obstet Gynaecol, 18(6): 550-552, 1998.
P. Van Trappen, P. De Sutter, M. Dhont. Vaginoplasty by inverted perineal and labia minora flaps – a retrospective study. J Obstet Gynaecol, 17(4): 379-382, 1997.
I. Buytaert, A. Elewaut, P. Van Trappen. Liver diseases in pregnancy. Belgian J Medecine, 52 (3): 213-216, 1996.
P. Van Trappen, R. Serreyn, C. De Potter. Estrogen receptor incidence in ductal carcinoma in-situ: estimated benefit following anti-estrogen therapy. Acta Clinica Belgica, 51(3): 205, 1996.
P. Van Trappen, R. Van den Broecke, H. Depypere, C. De Potter, R. Serreyn. Histopathology of microcalcifications in the breast and immunohistochemistry of ductal carcinoma in-situ lesions. Acta Clinica Belgica, 51(3): 207, 1996.
F.M. Belpaire, P. Wynant, P. Van Trappen, M. Dhont, A. Verstraete, M.G. Bogaert. Protein binding of propranolol and verapamil enantiomers in maternal and foetal serum. Br J Clin. Pharmac, 39: 190-193, 1995.
Hoofdstukken
PO Van Trappen, I Jacobs. Controversies and new trends in staging ovarian and fallopian tube carcinoma. Chapter 20. CME J Gynecol Oncol. 6: 260-266, 2001.
PO Van Trappen and IJ Jacobs. The genetics and molecular biology of gynaecological cancer. Gynaecology, Chapter 36: 527-543. Editors: R Shaw, WP Soutter, SL Stanton, 3rd Edition, 2003.
CD-ROM
Van Trappen P. Real-time quantitative reverse transcriptase-polymerase chain reaction for the detection of occult micrometastases in cervical cancer patients. Interactive CD-ROM of Gynaecological Oncology with 40 selected international speakers, IGCS, 1999.
21/10/2023: Invited Video-guided Lecture “Robotic-vaginal en bloc hysterectomy and total vaginectomy for early-stage vaginal melanoma” at the 2nd Annual Congress of the Society of Korean Robot Gynecologic Surgery, South-Korea.
04/10/2023: Invited Lecture “How to perform a successful Robotic Radical Hysterectomy for cervical cancer” at the European Society of Gynaecological Endoscopy (ESGE) Congress, Brussels.
03/10/2023: Organizer and Moderator Live Robotic Surgery at AZ Sint-Jan Hospital Bruges, robotic myomectomy and robotic sacrocolpopexy, for the European Society of Gynaecological Endoscopy (ESGE) Congress in Brussels.
09/06/2023: “Robotic para-aortic staging: who is eligible?” at the Society of European Robotic Gynaecological Surgeons (SERGS) in Athens
16/12/2022: Live Robotic GYN Surgery 4Health – Worldwide Robotic Surgery Events (WRSE12) –
16th December 2022 – International Faculty member – Semi-Live robotic surgery:
Video-recorded surgery
12/11/2022:
Hamburg Intensiv Seminar GYN-ONKO (1200 participants) – 12th November 2022 –
Lecture: “Robotic surgery in Gynecological Oncology: present and future”.
29/10/2022:
European Society of Gynecological Oncology (ESGO) Conference – Berlin – 29th
October Satellite Symposium Intuitive – Lecture: “Use of advanced energy in
pelvic and paraaortic lymph node dissection”.
3/10/2022:
European Society of Gynecological Endoscopy (ESGE) Conference – Lisbon – 3rd
October Satellite Symposium Intuitive – “Meet the professors” session: Lecture
“The value of da Vinci technology in endometrial cancer surgery”.
11/05/2022:
GYN CONNECT Robotics Forum Intuitive – Paris – 11th May 2022 – Lecturer.
6-8/4/2022:
Advanced Course in Robotic Gynaecological Oncology Surgery – joint ESGO-SERGS
(Society of European Robotic Gynecological Surgeons) course – ORSI Belgium –
6-8 April 2022. Master Proctor and Lecturer.
16-17/3/2022:
Peer-to-Peer Master Proctors Robotic Surgery – GYN Summit Intuitive Surgical –
IRCAD Strasbourg – 16-17 March 2022: Lecturer to Peers.
19/10/2021: Webinar European Society for Robotic Gynaecological Surgery (SERGS) – presentation “Robotic complex benign hysterectomy”, P. Van Trappen.
10/06/2021: Gyn Connect Up – International Forum (Intuitive Surgical Inc): presentation “Use of advanced robotic technologies for malignant procedures”, P. Van Trappen
17/3/2020: 1st Webinar SERGS: “Robotic vs Laparoscopic Surgery in Endometriosis”. P. Van Trappen.
7/02/2020: Voordracht voor de Wetenschappelijke Vereniging voor Verzekeringsgeneeskunde (WVV) aan Universiteit Antwerpen: “Chirurg en Robot: een nieuw onafscheidelijk duo”.
26-28/9/2019: 11th Annual SERGS (European Society of Robotic Gynaecological Surgery) meeting in Sofia (Bulgaria): Chairing the session on “Benign Robotic Surgery”; Panel member + presentation on “Endometriosis and Robotics”.
26-28/6/2019: Secondary Advanced Robotic Surgery Course in Gynaecological Oncology – Ghent (Melle) organised by ESGO-SERGS/Faculty members: T. Hebert (France), H. Falconer (Sweden), E. Lambaudie (France), P. Van Trappen (Belgium).
10-11/4/2019: Master Class + Live Surgery voor Robot chirurgie te Berlijn: “Robotic Surgery in Cervical Cancer”– Vivantes Klinikum – Berlin
11 mei 2019: Nationaal congres “Medische Wereld” te Brussel – VUB: “Medisch expert – Fonds voor Medische Ongevallen: efficiënte interactie?”
18 en 19 april 2018: Master Class + Live Surgery voor Robot chirurgie te Berlijn: “Robotic Surgery in Cervical Cancer” – Vivantes Klinikum – Berlin
VVOG congres 04/10/2018 te Mechelen: “Lokaal gevorderd cervix carcinoom”
27-28/09/2018 10th Annual SERGS meeting: Chairing Robot Benigne Gynaecology; Voordracht: Robotic surgery in large uterus
Voorzitter/organisator: Cursus Pelviene Oncologie voor assistenten VVOG, Gent, 20 oktober 2017.
Master Class Chirurgie Robotique, invited speaker: “Place des technologies avancées en chirurgie robotique”. Rennes (Bretagne), France, 13-14 oktober 2017.
Robot chirurgie in gynaecologische oncologie. Oncologie Symposium, De Valckaert, Oostkamp, 11 februari 2017.
Surgical Video day: Robotic radical hysterectomy and Robotic Para-aortic lymph node dissection. 7th Annual British and Irish Association of Robotic Gynaecological Surgeons (BIARGS), University of Leicester (UK), 1-3 maart 2017.
Robotic hysterectomy for a large uterus. 7th Annual British and Irish Association of Robotic Gynaecological Surgeons (BIARGS), University of Leicester (UK), 1-3 maart 2017.
Paradigm shift from laparoscopic to robotic surgery. 7th Annual British and Irish Association of Robotic Gynaecological Surgeons (BIARGS), University of Leicester (UK), 1-3 maart 2017.
Robot chirurgie in gynaecologie/oncologie. Navormingscursus operatieverpleegkundigen, VIVES Hogeschool, Brugge, 7 maart 2017.
Nieuwe Technieken voor behandeling van gynaecologische kankers. Vereniging “Actueel denken en leven”, Kinepolis Brugge, 1 maart 2016.
Robotic Devices – Video debate. 8th Annual Meeting on Robotic Gynaecological Surgery (SERGS), Barcelona (Spanje), 16-18 juni 2016.
Step-by-step Large Uterus Hysterectomy. 8th Annual Meeting on Robotic Gynaecological Surgery (SERGS), Barcelona (Spanje), 16-18 juni 2016.
Robotic surgery in Gynaecology/oncology in Bruges. ESM Intuitive Surgical, Barcelona (Spanje), 25 augustus 2016.
Chairman “New Frontiers in Gynaecological Cancer Management”, Gynaecologisch Oncologisch symposium, Concertgebouw Brugge, 1 oktober 2016.
“Ultra-radical surgery for ovarian cancer” at Royal Marsden Symposium on Surgical Aspects of Ovarian Cancer in London, 9 december 2011, Engeland.
“Bipolar Vessel Sealing Device in Gynaecologische/Oncologische Chirurgie”, voor de Apothekersvereniging van oost-en West-Vlaanderen, 20 oktober 2011, De Pinte, België.
“Endoscopic versus open surgery in endometrial cancer: outcomes” at International Symposium of Gynaecologic Surgery: from benign to cancer – State of the art, Cefalu (Sicily), 27 mei 2011, Italië.
“Primaire en intervaldebulkingchirurgie bij ovariumcarcinoom: state-of-the-art. KHBO Permanante vorming ‘Operatieverpleegkunde’. Brugge, 22 februari 2011.
“Gynaecologische Oncologische Chirurgie: de grenzen verleggen”. AZ Colloquia St.-Jan Brugge. 21 december 2010 en Permanente vorming 2011 Verpleegkundigen heelkunde – operatiekwartier – campus Brugge, 5 apil 2011.
“Chirurgie van vergevorderd ovarium carcinoom”. LOK 0317 – WGSV in Zeeland, 25 september 2010.
“Nieuwe perspectieven in de gynaecologische oncologie”. Voordracht voor artsengroep “Houtland” te Torhout, 14 oktober 2010.
“Surgical treatment of ovarian cancer” at regional doctors meeting Stockholm-Gotland, at Elite Palace Hotel, Stockholm (Sweden) 11 december 2009.
“Surgical treatment of Breast Cancer: what … and why”. Breast Cancer Symposium (Breast Clinic: FAQ) at ’t Pand Ghent, from AZ Jan Palfijn Hospital Ghent, Belgium, 25 April 2009.
“Gynaecologische tumoren: internationale richtlijnen en nieuwe perspectieven.”. Symposium Oncologie – AZ Jan Palfijn 7 juni 2008.
“Technics en Genetics bij cervix, ovarium en mammacarcinoom”. HAVRA huisartsengroep, Aalter, 31 januari 2008, België.
“Vaccinatie ter preventie van het cervix carcinoom”, Randwijck cursus, azM, Maastricht, 27 maart 2007, Nederland.
“De toegevoegde waarde van MRI in de risk of malignancy index. Keynote Lecture voor de gynaecologische oncologie op Doelen Congres Obstetrie/Gynaecologie & Infertiliteit te Rotterdam, 19 april 2007, Nederland.
“Oncologische chirurgie en Robot chirurgie in de gynaecologie”. Lok vergadering Aalst, 30 oktober 2007, België.
“Technics en Genetics bij cervix, ovarium en mammacarcinoom”. Huisartsenvereniging Hippoliet van Peene, Eeklo, 8 november 2007, België.
“Laparoscopie in de gynaecologische oncologie”, Veldhoven refereeravond, 14 november 2006, Nederland.
“From bench to bedside in gynaecological oncology”. VVOG, Overijse (Belgium), 1st October 2005, België.
“Management of early-stage cervical cancer”. North-East Thames specialist registrars meeting. Lecture at The Royal London Hospital, on the 9th January 2004, Engeland.
“Lymphangiogenesis and lymph node metastases”. 13th Meeting of the European Society of Gynaecological Oncology, Brussels, 8th April 2003, België.
“Molecular events in cervical cancer”. University Charles of Prague. Department of Obstetrics & Gynaecology (Prof. Lukas Rob), 19th May 2004, Prague, Czech Republic.
“Progress in Gynaecological Cancer Research”, Karolinska Institute – Stockholm, Sweden. Department of Gynaecological Oncology (Prof. E.A. Lundquist), on 14th June 2004, Zweden.
“Molecular Determinants of Cervical Cancer Progression”. 7th International Conference on Anti-cancer Research. Corfu, Greece. 25-30 October 2004, Griekenland.
“Cervical Cancer Screening”. Joint London course in Oncology. Lecture at Royal College of Radiologists, on the 11th December 2003, Engeland.
“Angiogenesis and Lymphangiogenesis in Gynaecological Cancers”. Dutch Society of Gynaecological Oncology/COBRA; “Metastatic tumours and recurrences”. Utrecht, 12-13th December 2002, Nederland.
“Ovarian Cancer Screening”. Lecture for registrars in Medical Oncology London, Royal College of Radiologists, 9th January 2002, Engeland.
“Assessing malignant potential of an adnexal mass”. North-East Thames Gynaecology Meeting, University College Hospital, London, 14th June 2002, Engeland.
“Management of early-stage cervical cancer”. North-East Thames trainees in Obstetrics and Gynaecology, Royal London Hospital, London, 22 November 2002, Engeland.
“Novel molecular diagnostic approaches to identify genetic events in ovarian cancer”. Free University Amsterdam, 29 March, 2001, Nederland.
“Metastasis and Angiogenesis”. Panel member. Helene Harris Memorial Trust: 8th Biennial International Forum on ovarian cancer. MD Anderson Cancer Centre, Houston, USA, 20 March 2001, United States.
“Molecular diagnosis and staging”. Annual British Gynaecological Cancer Society Meeting, London, 14 November 2001, Engeland.
“Molecular Technology in Gynaecological Cancer”. Chairman of workshop. Annual British Gynaecological Cancer Society Meeting, London, 15 November 2001, Engeland.
“Molecular events in angiogenesis/lymphangiogenesis”. ICRF Medical Oncology Seminars, London, 31 January 2001, Engeland.
“Detection of micrometastases by means of molecular biology”. University of Innsbruck (Prof. Ch. Marth), Austria, January 2000, Oostenrijk.
“Molecular Staging in Cervical Cancer”. The VIII Meeting of the International Gynaecologic Cancer Society at Buenos Aires (Argentina), October 22-26, 2000, Argentinië.
“Novel Diagnostic Approaches to Cervical and Ovarian Cancer”. Workshop: “Molecular Biology: any good news?” Buenos Aires (Argentina), October 26, 2000, Argentinië.
“Angiogenesis and Micrometastases in Cervical Cancer”. Grand Round, Barts and the London NHS Trust, March 7, 2000, Engeland.
“Imaging of an adnexal mass”. Academic meeting of Obstetrics and Gynaecology, London, April 14, 2000, Engeland.
“Molecular quantification of micrometastases”. 1st workshop in molecular genetics of cancer, St. Bartholomew’s Hospital, London, May 30, 2000, Engeland.
“Tumour Angiogenesis and Micrometastasis”, Research Scientist Forum, Queen Mary and Westfield College, London, 3rd October, 2000, Engeland.
“The genetics of angiogenesis – A computer based 3D model”. William Harvey Day, Queen Mary University London, 17 October 2000, London, Engeland.
“Molecular staging of cervical cancer using real-time RT-PCR: correlation between number of cancer cells in normal lymph nodes and prognostic features”. The 31st Society of Gynaecologic Oncology Meeting, San Diego, USA, February 4-8, 2000, United States.
“Molecular profiling of angiogenesis and occult micrometastases in cervical cancer”. The British Cancer Research Meeting, Brighton, July 10-12, 2000, Engeland.
“Molecular Staging in Cervical Cancer”. The VIII Meeting of the International Gynecologic Cancer Society at Buenos Aires (Argentina), October 22-26, 2000, Argentinië.
“Tumour Markers, MRI, Radioimmunoscintigraphy, ultrasound and doppler in the differential diagnosis of benign and malignant adnexal masses”. Academic meeting of Gynaecological Oncology, January 8, 1999, Royal London Hospital, Engeland.
“Molecular Staging of Gynaecological Cancer”. Association of North Thames (East) Obstetricians & Gynaecologists, Annual Meeting London, November 19, 1999, Engeland.
“Molecular detection of submicroscopic disease”. Oncology Workshop, Erlangen University, Germany, November 1999, Duitsland.
“Molecular detection of metastatic disease in gynaecological cancer using quantitative RT-PCR for cytokeratin 19”. Selected for oral presentation at the 11th International Meeting of the European Society of Gynaecological Oncology at Budapest (Hungary), 8-12 May 1999, Hongarije.
“Real-time quantitative reverse transcriptase-polymerase chain reaction for the detection of occult micrometastases in cervical cancer patients”. Selected for oral presentation at the 7th Biennial Meeting of the International Gynaecologic Cancer Society at Vatican City (Italy), September 26-30, 1999 and at the Beatson International Cancer Conference “Invasion and Metastasis”, Glasgow, June 26-29, 1999, Schotland.
“Molecular staging in cervical cancer using real-time quantitative RT-PCR: how many cancer cells in the lymph nodes are needed to become clinically significant”. The British Gynaecological Cancer Society meeting in London, November, 1999, Engeland.
“Cytoskeletal aberrations as predictors of invasion in gynaecological cancers”. Royal London Hospital on 29th April 1998 (Queen Mary and Westfield College), London, Engeland.
“Haptoglobin-phenotype: incidentie en klinisch verloop van preeclampsie”. Internationaal Symposium van de NVOG en de VVOG, 1997, Nederland.
“Resultaten van de Bhonsale – vaginoplasty: een retrospectieve studie”. Jaarlijkse vergadering van de Vereniging voor Fertiliteitsstudie van Vlaanderen en Nederland, Corsendonck, 1996, België.
“Estrogen receptor incidence in ductal carcinoma in-situ: estimated benefit following anti-estrogen therapy”. Scientific meeting of the Belgian Association for Cancer Research, 1996: Breast Cancer – Advances and controversies, België.
“Suspicious microcalcifications in the breast: correlation with histopathology”. Advanced course of Breast Cancer, at the European School of Oncology, Milan, Italy, 1995, Italië.
“Endometriose van de blaas”. Nationaal Kongres van de Koninklijke Belgische Vereniging voor Gynaecologie en Verloskunde, Brussel, 1994, België.
“Acute leversteatose in de zwangerschap”. Nationaal Kongres van de Koninklijke Belgische Vereniging voor Gynaecologie en Verloskunde, Brussel, 1993, België.
2022-heden Academic Committee Member Society of European Robotic Gynaecological Surgeons (SERGS)
2017-2021 Council Member Society of European Robotic Gynaecological Surgeons (SERGS)
2016-2019 Voorzitter BIG Pelviene Oncologie VVOG (Pelvic Oncology Group Flemish Organisation VVOG)
2013-2016 Secretaris werkgroep gynaecologische oncologie VVOG
2010-heden Gynaecoloog/Oncoloog en Diensthoofd Gynaecologie/Oncologie AZ Sint-Jan Brugge AV, België
2009-2010 Senior Consultant (Overläkare) Surgeon Gynaecologie/Oncologie in Karolinska University Hospital, Stockholm, Zweden
2007-2009 Gynaecoloog/Oncoloog in AZ Jan Palfijn Ziekenhuis Gent, coördinatie Gynaecologisch Oncologisch Centrum en Borstkliniek, België
2006-2007 Gewoon Hoogleraar (Professor) en Hoofd Gynaecologie & Gynaecologische Oncologie, Academisch Ziekenhuis Maastricht, Nederland
2005-2006 Consultant en Clinical Senior Lecturer (Associate-Professor) Gynaecologische Oncologie, Gynaecological Cancer Centre, St. Bartholomew’s Hospital, London, Engeland
2001-2004 Senior Fellow Gynaecologische Oncologie (“Royal College of Obstetricians and Gynaecologists”), St. Bartholomew’s Hospital & The Royal Marsden Hospital – London (Prof. John Shepherd and Prof. Ian Jacobs); Fellow darmchirurgie, Royal London Hospital (Prof. Sina Dorudi) & Old Church Hospital (Romford; Mr. Clive Hepworth), Engeland
2002-2004 Cancer Research UK Clinician Scientist, Translational Oncology Laboratory, St. Bartholomew’s Hospital, London, Engeland
1998-2001 Clinical Research Fellow (PhD), Gynaecological Oncology Unit (Prof. Ian Jacobs), St. Bartholomew’s Hospital, London, Engeland
1992-1997 Specialist in opleiding in Verloskunde, Gynaecologie en Infertiliteit, Universitair Ziekenhuis Gent, België en St. Elisabeth Ziekenhuis Tilburg, Nederland
1990-1991 Vertegenwoordiger medische studenten België voor het “Erasmus project”
1989-1990 Praeses medische studentenorganisatie Gent (VKG), België
1988-1989 Vice-Praeses medische studentenorganisatie Gent (VKG), België
2015-heden European Society of European Robotic Gynaecological Surgeons (SERGS)
1999-heden European Society of Gynaecological Oncology (ESGO)
2006-heden International Gynaecological Cancer Society (IGCS)
1997-heden Vlaamse Vereniging voor Obstetrie en Gynaecologie (VVOG)
2005-heden Faculty Member of Faculty of 1000 Medicine: Gynaecological Cancer Group
http://www.f1000medicine.com
2010-heden Academia: independent.academia.edu/PhilippeVanTrappen
Yasnaia Bruneel, Christophe Ghysel, Caroline Van Holsbeke, Philippe Van Trappen. Fluorescence guidance during robotic resection of bladder wall endometriosis: case report and technique, Journal of Surgical Case Reports, Volume 2023, Issue 10, October 2023, rjad604. doi: 10.1093/jscr/rjad604
Lesseliers T, Van Trappen P (November 20, 2023) Robotic Vaginal Cuff Closure During Radical Hysterectomy for Early-Stage Cervical Cancer: The Bruges Method. Cureus 15(11): e49149. DOI 10.7759/cureus.49149
Van Trappen P. Robotic para-aortic sentinel lymph node mapping in endometrial, cervical, and ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 2023 Aug 10;90:102402. doi: 10.1016/j.bpobgyn.2023.102402.
Lebbe I, De Cuypere E, Claes N, Loccufier A, Ghysel C, Van Trappen P. Primary leiomyosarcoma of the uterine cervix: an unusual case and critical appraisal. J Surg Case Rep. 2023 Aug 4;2023(8):rjad439. doi: 10.1093/jscr/rjad439.
Van Trappen P, Lebbe I, De Cuypere E, Claes N. Case report: a robotic-vaginal approach for total vaginectomy and hysterectomy with pelvic sentinel lymph node dissection in primary vaginal melanoma: a 10-step technique and literature review. Front Surg. 2023 May 26;10:1189196. doi: 10.3389/fsurg.2023.1189196.
Van Trappen P, de Cuypere E, Claes N. Robotic surgery in early and advanced ovarian cancer: Case selection for surgical staging and interval debulking surgery. Eur J Obstet Gynecol Reprod Biol. 2023 Jan;280:7-11. doi: 10.1016/j.ejogrb.2022.11.005.
Van Trappen P, De Cuypere E, Claes N, Roels S. Robotic Staging of Cervical Cancer With Simultaneous Detection of Primary Pelvic and Secondary Para-Aortic Sentinel Lymph Nodes: Reproducibility in a First Case Series. Front Surg. 2022 Jun 16;9:905083. doi: 10.3389/fsurg.2022.905083. PMID: 35784928; PMCID: PMC9244622.
Van Trappen P. Indocyanine green guidance for combined robotic pelvic and para-aortic sentinel node mapping in cervical cancer. Surg Oncol. 2022 May;41:101745. doi: 10.1016/j.suronc.2022.101745. Epub 2022 Mar 26. PMID: 35358912.
Delrue C, Vanwalleghem L, Paepe P, Van Trappen P. Stratified Mucin-producing Intraepithelial Lesions of the Cervix: Clinical Diversity of Cases and Literature Review. Anticancer Res. 2022 Feb;42(2):1175-1180. doi: 10.21873/anticanres.15583. PMID: 35093923.
Dumont S, Van Trappen P. The clinical and financial impact of introducing robotic-assisted hysterectomy in a tertiary referral centre: A direct cost analysis of consecutive hysterectomies during a decade. Int J Med Robot. 2021 Oct 16:e2343. doi: 10.1002/rcs.2343. Epub ahead of print. PMID: 34655461.
de Bruyn A, Peeters F, Smulders K, Goffin F, Traen K, Van Trappen P, Vergote I. Observational BGOG Study of the Results of Robot-assisted Laparoscopy in 166 Patients with FIGO 2009 Stage IA1-IB1 Cervical Cancer. J Minim Invasive Gynecol. 2021 Nov;28(11):1920-1926. doi: 10.1016/j.jmig.2021.05.001. Epub 2021 May 14. PMID: 34000393.
Kakkos A, Ver Eecke C, Ongaro S, Traen K, Peeters F, Van Trappen P, Laenen A, Despierre E, Van Nieuwenhuysen E, Vergote I, Goffin F. Robot-assisted surgery for women with endometrial cancer: Surgical and oncologic outcomes within a Belgium gynaecological oncology group cohort. Eur J Surg Oncol. 2021 May;47(5):1117-1123. doi: 10.1016/j.ejso.2020.10.005. Epub 2020 Oct 13. PMID: 33268212.
Persyn B, Van Trappen P. Robotic Hysterectomy Using a Sealing Device: Differences In Complications and Pain Scores Between Small and Large Uteri. Surg Technol Int. 2020 Jun 10;37:sti37/1309. Online ahead of print. PMID: 32520389. https://pubmed.ncbi.nlm.nih.gov/32520389/
Vlaamse Vereniging voor Obstetrie en Gynaecologie (VVOG): “Aanbevelingen bij diagnose en behandeling van cervix carcinoom.” Ph. Van Trappen, namens de VWOG en BIG Pelviene Oncologie 2016-2019. Gunaïkeia, 2020.
Bénédicte Persyn, Philippe Van Trappen. Leverkapselruptuur bij normotensief HELLP-syndroom. Gunaïkeia Vol 24 nr 5, 2019.
Vergote I, Magrina JF, Zanagnolo V, Magtibay PM, Butler K, Gil-Moreno A, Feijoo BD, Kimmig R, Canis M, Bourdel N, Ind T, Estape R, Persson J, Lim P, Coronado P, Ponce J, Lambaudie E, Van Gorp T, Maggioni A, Narducci F, Van Niewwenhuysen E, Van Trappen P. The LACC Trial and Minimally Invasive Surgery in Cervical Cancer. J Minim Invasive Gynecol. 2020 Feb;27(2):462-463. doi: 10.1016/j.jmig.2019.09.767. Epub 2019 Sep 11.
Martin Rudnicki, Philippe van Trappen, Paul van Kesteren. Hysterectomy-Should All Residents Learn to Perform It? Editorial Acta Obstet Gynecol Scand. 2019 Jan;98(1):5-6. doi: 10.1111/aogs.13507.
Rudnicki M, Van Trappen P, van Kesteren P. Hysterectomy-Who should be trained to do it? Acta Obstet Gynecol Scand. 2019 Jun;98(6):814. doi: 10.1111/aogs.13571.
Maggen C, Van Huysse J, Van Trappen P. Simple Vaginal Trachelectomy for Small Volume Cervical Cancer: Case Report and Review of the Literature. EC Gynaecology 5.3(2017):83-90.
Neutens S, Van Trappen P. Eerste Robotgeassisteerde Fertiliteitsparende Baarmoederhalskankeroperatie in Vlaanderen. AZ Link (Sint-Jan Brugge) 35:7-9, 2017.
Coryn N, Serkei E, Weyers S, Van Trappen P. De pil Anno 2016: welke keuze en waarom? Tijdschr. voor Geneeskunde, 72, nr 18, 2016.
Hoste G, Van Trappen P. Robotic hysterectomy using the Vessel Sealer for myomatous uteri: technique and clinical outcome. Eur J Obstet Gynecol Reprod Biol. 2015 Sep 30;194:241-244.
Segaert A, Traen K, Van Trappen P, Peeters F, Leunen K, Goffin F, Vergote I. Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience. Int J Gynecol Cancer. 2015 Nov;25(9):1690-6.
Sap K, Van Trappen Ph. Paradigm shift in the management of gynaecological cancers. EMJ Oncol 2015;3:12–8.
P. Van Trappen. Centralisatie door regionalisatie van gynaecologische kankerzorg: Europees model? Gunaikeia, Vol 20;3:29-33,2015.
De Greve T, Vanwalleghem L, Van Hoof A, Coenegrachts K, Van Trappen P. An unusual cervical tumor as presentation of a non-hodgkin lymphoma. Case Rep Obstet Gynecol. 2014;2014:549619.
Mehra G, Weekes A, Vantrappen P, Visvanathan D, Jeyarajah A. Laparoscopic assisted radical vaginal hysterectomy for cervical carcinoma: morbidity and long-term follow-up. Eur J Surg Oncol. 2010 Mar;36(3):304-8.
Kruse AJ, Bottenberg MJ, Tosserams J, Slangen B, van Marion AM, van Trappen PO. The absence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to the HPV-independent pathway as the causative agent for vulvar squamous cell carcinoma and its precursor simplex VIN in a young patient. Int J Gynecol Pathol. 2008 Oct;27(4):591-5.
S Bishara, M Griffin, A Cargill, A Bali, ME Gore, SB Kaye, JH Shepherd, PO Van Trappen.Pre-treatment white blood cell subtypes as prognostic indicators in ovarian cancer. Eur J Obstet Gynecol. 138:71-75, 2008.
PO Van Trappen, B Rufford, TD Mills, SA Sohaib, JAW Webb, A Sahdev, N Ali, MJ Carroll, KE Britton, RH Reznek, IJ Jacobs. Differential diagnosis of adnexal masses: risk of malignancy index, ultrasonography, MR imaging and radioimmunoscintigraphy. Int J Gynecol Cancer, 17:61-67, 2007.
T Hagemann, T Bozanovic, S Hooper, A Ljubic, VIF Slettenaar, JL Wilson, N Singh, SA Gayther, JH Shepherd, PO Van Trappen. Molecular profiling of primary cervical cancers, lymph node micrometastases and recurrent tumours. Br J Cancer, 96: 321-328, 2007.
PO Van Trappen, T Cullup, R Troke, S Gayther, D Swann, C Mein. Somatic mitochondrial DNA mutations and polymorphisms in primary and metastatic ovarian cancer. Gynecol Oncol, 104: 129-133, 2007.
J Balega, PO Van Trappen. The sentinel lymph node in gynaecological malignancy. Cancer Imaging, 28(6): 7-15, 2006.
PO Van Trappen and MS Pepper. Lymphangiogenesis in female reproductive cancers. Angiogenesis, 8(2): 137-145, 2005.
SA Sohaib, TD Mills, A Sahdev, JA Webb, PO Van Trappen, I Jacobs and RH Reznek. The role of MRI in patients with adnexal masses identified on ultrasound. J Clin Radiol, 60: 340-348, 2005.
T. Bozanovic and PO Van Trappen. Gynaecological cancer and genetics. Cervical cancer and genetics. Gynaecology Forum, 10(1): 24-27, 2005.
A Bali, A Weekes, P Van Trappen, A Jeyarajah, D Querleu. Central pelvic recurrence seven years after radical vaginal trachelectomy. Gynecol Oncol, 96: 854-856, 2005.
PO Van Trappen, D Steele, DG Lowe, S Baithun, P Levey, N Beasley, J Krishnan, JH Shepherd, MS Pepper, D Jackson, JP Sleeman, IJ Jacobs. Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during the different stages of cervical carcinogenesis. J Pathol, 201: 544-554, 2003.
G Zhu, L Reynolds, T Crnogorac-Jurcevic, CE Gillett, EA Dublin, JF Marshall, D Barnes, C D’Arrigo, PO Van Trappen, NR Lemoine and IR Hart. Combination Of Microdissection And Microarray Analysis To Identify Gene Expression Changes Between Differentially Located Tumor Cells In Breast Cancer. Oncogene, 22: 3742-3748, 2003.
SAA Sohaib, A Sahdev, PO Van Trappen, I Jacobs, RH Reznek. Characterisation of adnexal mass lesions on magnetic resonance imaging. Am J Radiol, 180: 1297-1304, 2003.
EC Kohn, IJ Fidler, D Fishman, R Jaffe, LA Liotta, P Van Trappen, GB Mills, C Trope. Discussion: Metastasis and angiogenesis in epithelial ovarian cancer. Gynecol Oncol, 88: S37-S42, 2003.
N Ali, H Jan, PO Van Trappen, F Nasreen, A Canizales, MJ Carroll, M Granowska, IJ Jacobs, KE Britton. Tc-99m SM3 radioimmunoscintigraphy (RIS) and its distinction between malignant and benign adnexal masses. Br J Obstet Gynaecol, 110: 508-514, 2003.
PO Van Trappen and MS Pepper. Lymphatic dissemination of tumour cells and the formation of tumour micrometastases. Lancet Oncol, 3: 44-52, 2002.
Beasley NJP, Prevo R, Banerji S, Leek R, Moore J, Van Trappen PO, Cox G, Harris AL, Jackson DG. Intratumoural lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res, 62: 1315-1320, 2002.
PO Van Trappen, A Ryan, M Carroll, C Lecoeur, L Goff, V Gyselman, B Young, D Lowe, MS Pepper, JH Shepherd, I Jacobs. A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer. Br J Cancer, 87: 537-544, 2002.
Van Trappen PO, Gyselman VG, Lowe DG, Ryan A, Oram DH, Bosze P, Weekes AR, Shepherd JH, Dorudi S, Bustin SA, Jacobs IJ. Molecular quantification and mapping of lymph node micrometastases in cervical cancer. The Lancet, 357: 15-20, 2001.
PO Van Trappen, MS Pepper. Lymphangiogenesis and lymph node microdissemination. Gynecol Oncol, 82: 1-3, 2001.
P. Van Trappen, R. Serreyn, A. E. Elewaut, V. Cocquyt, S. Van Belle. Abdominal pain with anorexia in patients with breast carcinoma. Ann Oncol, 9: 1243-1245, 1998.
P. Van Trappen. Screening and Diagnosis of Gynaecological Cancers: pre-operative assessment of the adnexal mass. The Diplomate (RCOG), 5(3): 208-214, 1998.
P. Van Trappen, K. Verbeken, M. Temmerman. Pre-eclampsia and chromosomal anomalies. J Obstet Gynaecol, 18(6): 550-552, 1998.
P. Van Trappen, P. De Sutter, M. Dhont. Vaginoplasty by inverted perineal and labia minora flaps – a retrospective study. J Obstet Gynaecol, 17(4): 379-382, 1997.
I. Buytaert, A. Elewaut, P. Van Trappen. Liver diseases in pregnancy. Belgian J Medecine, 52 (3): 213-216, 1996.
P. Van Trappen, R. Serreyn, C. De Potter. Estrogen receptor incidence in ductal carcinoma in-situ: estimated benefit following anti-estrogen therapy. Acta Clinica Belgica, 51(3): 205, 1996.
P. Van Trappen, R. Van den Broecke, H. Depypere, C. De Potter, R. Serreyn. Histopathology of microcalcifications in the breast and immunohistochemistry of ductal carcinoma in-situ lesions. Acta Clinica Belgica, 51(3): 207, 1996.
F.M. Belpaire, P. Wynant, P. Van Trappen, M. Dhont, A. Verstraete, M.G. Bogaert. Protein binding of propranolol and verapamil enantiomers in maternal and foetal serum. Br J Clin. Pharmac, 39: 190-193, 1995.
Hoofdstukken
PO Van Trappen, I Jacobs. Controversies and new trends in staging ovarian and fallopian tube carcinoma. Chapter 20. CME J Gynecol Oncol. 6: 260-266, 2001.
PO Van Trappen and IJ Jacobs. The genetics and molecular biology of gynaecological cancer. Gynaecology, Chapter 36: 527-543. Editors: R Shaw, WP Soutter, SL Stanton, 3rd Edition, 2003.
CD-ROM
Van Trappen P. Real-time quantitative reverse transcriptase-polymerase chain reaction for the detection of occult micrometastases in cervical cancer patients. Interactive CD-ROM of Gynaecological Oncology with 40 selected international speakers, IGCS, 1999.
21/10/2023: Invited Video-guided Lecture “Robotic-vaginal en bloc hysterectomy and total vaginectomy for early-stage vaginal melanoma” at the 2nd Annual Congress of the Society of Korean Robot Gynecologic Surgery, South-Korea.
04/10/2023: Invited Lecture “How to perform a successful Robotic Radical Hysterectomy for cervical cancer” at the European Society of Gynaecological Endoscopy (ESGE) Congress, Brussels.
03/10/2023: Organizer and Moderator Live Robotic Surgery at AZ Sint-Jan Hospital Bruges, robotic myomectomy and robotic sacrocolpopexy, for the European Society of Gynaecological Endoscopy (ESGE) Congress in Brussels.
09/06/2023: “Robotic para-aortic staging: who is eligible?” at the Society of European Robotic Gynaecological Surgeons (SERGS) in Athens
16/12/2022: Live Robotic GYN Surgery 4Health – Worldwide Robotic Surgery Events (WRSE12) –
16th December 2022 – International Faculty member – Semi-Live robotic surgery:
Video-recorded surgery
12/11/2022:
Hamburg Intensiv Seminar GYN-ONKO (1200 participants) – 12th November 2022 –
Lecture: “Robotic surgery in Gynecological Oncology: present and future”.
29/10/2022:
European Society of Gynecological Oncology (ESGO) Conference – Berlin – 29th
October Satellite Symposium Intuitive – Lecture: “Use of advanced energy in
pelvic and paraaortic lymph node dissection”.
3/10/2022:
European Society of Gynecological Endoscopy (ESGE) Conference – Lisbon – 3rd
October Satellite Symposium Intuitive – “Meet the professors” session: Lecture
“The value of da Vinci technology in endometrial cancer surgery”.
11/05/2022:
GYN CONNECT Robotics Forum Intuitive – Paris – 11th May 2022 – Lecturer.
6-8/4/2022:
Advanced Course in Robotic Gynaecological Oncology Surgery – joint ESGO-SERGS
(Society of European Robotic Gynecological Surgeons) course – ORSI Belgium –
6-8 April 2022. Master Proctor and Lecturer.
16-17/3/2022:
Peer-to-Peer Master Proctors Robotic Surgery – GYN Summit Intuitive Surgical –
IRCAD Strasbourg – 16-17 March 2022: Lecturer to Peers.
19/10/2021: Webinar European Society for Robotic Gynaecological Surgery (SERGS) – presentation “Robotic complex benign hysterectomy”, P. Van Trappen.
10/06/2021: Gyn Connect Up – International Forum (Intuitive Surgical Inc): presentation “Use of advanced robotic technologies for malignant procedures”, P. Van Trappen
17/3/2020: 1st Webinar SERGS: “Robotic vs Laparoscopic Surgery in Endometriosis”. P. Van Trappen.
7/02/2020: Voordracht voor de Wetenschappelijke Vereniging voor Verzekeringsgeneeskunde (WVV) aan Universiteit Antwerpen: “Chirurg en Robot: een nieuw onafscheidelijk duo”.
26-28/9/2019: 11th Annual SERGS (European Society of Robotic Gynaecological Surgery) meeting in Sofia (Bulgaria): Chairing the session on “Benign Robotic Surgery”; Panel member + presentation on “Endometriosis and Robotics”.
26-28/6/2019: Secondary Advanced Robotic Surgery Course in Gynaecological Oncology – Ghent (Melle) organised by ESGO-SERGS/Faculty members: T. Hebert (France), H. Falconer (Sweden), E. Lambaudie (France), P. Van Trappen (Belgium).
10-11/4/2019: Master Class + Live Surgery voor Robot chirurgie te Berlijn: “Robotic Surgery in Cervical Cancer”– Vivantes Klinikum – Berlin
11 mei 2019: Nationaal congres “Medische Wereld” te Brussel – VUB: “Medisch expert – Fonds voor Medische Ongevallen: efficiënte interactie?”
18 en 19 april 2018: Master Class + Live Surgery voor Robot chirurgie te Berlijn: “Robotic Surgery in Cervical Cancer” – Vivantes Klinikum – Berlin
VVOG congres 04/10/2018 te Mechelen: “Lokaal gevorderd cervix carcinoom”
27-28/09/2018 10th Annual SERGS meeting: Chairing Robot Benigne Gynaecology; Voordracht: Robotic surgery in large uterus
Voorzitter/organisator: Cursus Pelviene Oncologie voor assistenten VVOG, Gent, 20 oktober 2017.
Master Class Chirurgie Robotique, invited speaker: “Place des technologies avancées en chirurgie robotique”. Rennes (Bretagne), France, 13-14 oktober 2017.
Robot chirurgie in gynaecologische oncologie. Oncologie Symposium, De Valckaert, Oostkamp, 11 februari 2017.
Surgical Video day: Robotic radical hysterectomy and Robotic Para-aortic lymph node dissection. 7th Annual British and Irish Association of Robotic Gynaecological Surgeons (BIARGS), University of Leicester (UK), 1-3 maart 2017.
Robotic hysterectomy for a large uterus. 7th Annual British and Irish Association of Robotic Gynaecological Surgeons (BIARGS), University of Leicester (UK), 1-3 maart 2017.
Paradigm shift from laparoscopic to robotic surgery. 7th Annual British and Irish Association of Robotic Gynaecological Surgeons (BIARGS), University of Leicester (UK), 1-3 maart 2017.
Robot chirurgie in gynaecologie/oncologie. Navormingscursus operatieverpleegkundigen, VIVES Hogeschool, Brugge, 7 maart 2017.
Nieuwe Technieken voor behandeling van gynaecologische kankers. Vereniging “Actueel denken en leven”, Kinepolis Brugge, 1 maart 2016.
Robotic Devices – Video debate. 8th Annual Meeting on Robotic Gynaecological Surgery (SERGS), Barcelona (Spanje), 16-18 juni 2016.
Step-by-step Large Uterus Hysterectomy. 8th Annual Meeting on Robotic Gynaecological Surgery (SERGS), Barcelona (Spanje), 16-18 juni 2016.
Robotic surgery in Gynaecology/oncology in Bruges. ESM Intuitive Surgical, Barcelona (Spanje), 25 augustus 2016.
Chairman “New Frontiers in Gynaecological Cancer Management”, Gynaecologisch Oncologisch symposium, Concertgebouw Brugge, 1 oktober 2016.
“Ultra-radical surgery for ovarian cancer” at Royal Marsden Symposium on Surgical Aspects of Ovarian Cancer in London, 9 december 2011, Engeland.
“Bipolar Vessel Sealing Device in Gynaecologische/Oncologische Chirurgie”, voor de Apothekersvereniging van oost-en West-Vlaanderen, 20 oktober 2011, De Pinte, België.
“Endoscopic versus open surgery in endometrial cancer: outcomes” at International Symposium of Gynaecologic Surgery: from benign to cancer – State of the art, Cefalu (Sicily), 27 mei 2011, Italië.
“Primaire en intervaldebulkingchirurgie bij ovariumcarcinoom: state-of-the-art. KHBO Permanante vorming ‘Operatieverpleegkunde’. Brugge, 22 februari 2011.
“Gynaecologische Oncologische Chirurgie: de grenzen verleggen”. AZ Colloquia St.-Jan Brugge. 21 december 2010 en Permanente vorming 2011 Verpleegkundigen heelkunde – operatiekwartier – campus Brugge, 5 apil 2011.
“Chirurgie van vergevorderd ovarium carcinoom”. LOK 0317 – WGSV in Zeeland, 25 september 2010.
“Nieuwe perspectieven in de gynaecologische oncologie”. Voordracht voor artsengroep “Houtland” te Torhout, 14 oktober 2010.
“Surgical treatment of ovarian cancer” at regional doctors meeting Stockholm-Gotland, at Elite Palace Hotel, Stockholm (Sweden) 11 december 2009.
“Surgical treatment of Breast Cancer: what … and why”. Breast Cancer Symposium (Breast Clinic: FAQ) at ’t Pand Ghent, from AZ Jan Palfijn Hospital Ghent, Belgium, 25 April 2009.
“Gynaecologische tumoren: internationale richtlijnen en nieuwe perspectieven.”. Symposium Oncologie – AZ Jan Palfijn 7 juni 2008.
“Technics en Genetics bij cervix, ovarium en mammacarcinoom”. HAVRA huisartsengroep, Aalter, 31 januari 2008, België.
“Vaccinatie ter preventie van het cervix carcinoom”, Randwijck cursus, azM, Maastricht, 27 maart 2007, Nederland.
“De toegevoegde waarde van MRI in de risk of malignancy index. Keynote Lecture voor de gynaecologische oncologie op Doelen Congres Obstetrie/Gynaecologie & Infertiliteit te Rotterdam, 19 april 2007, Nederland.
“Oncologische chirurgie en Robot chirurgie in de gynaecologie”. Lok vergadering Aalst, 30 oktober 2007, België.
“Technics en Genetics bij cervix, ovarium en mammacarcinoom”. Huisartsenvereniging Hippoliet van Peene, Eeklo, 8 november 2007, België.
“Laparoscopie in de gynaecologische oncologie”, Veldhoven refereeravond, 14 november 2006, Nederland.
“From bench to bedside in gynaecological oncology”. VVOG, Overijse (Belgium), 1st October 2005, België.
“Management of early-stage cervical cancer”. North-East Thames specialist registrars meeting. Lecture at The Royal London Hospital, on the 9th January 2004, Engeland.
“Lymphangiogenesis and lymph node metastases”. 13th Meeting of the European Society of Gynaecological Oncology, Brussels, 8th April 2003, België.
“Molecular events in cervical cancer”. University Charles of Prague. Department of Obstetrics & Gynaecology (Prof. Lukas Rob), 19th May 2004, Prague, Czech Republic.
“Progress in Gynaecological Cancer Research”, Karolinska Institute – Stockholm, Sweden. Department of Gynaecological Oncology (Prof. E.A. Lundquist), on 14th June 2004, Zweden.
“Molecular Determinants of Cervical Cancer Progression”. 7th International Conference on Anti-cancer Research. Corfu, Greece. 25-30 October 2004, Griekenland.
“Cervical Cancer Screening”. Joint London course in Oncology. Lecture at Royal College of Radiologists, on the 11th December 2003, Engeland.
“Angiogenesis and Lymphangiogenesis in Gynaecological Cancers”. Dutch Society of Gynaecological Oncology/COBRA; “Metastatic tumours and recurrences”. Utrecht, 12-13th December 2002, Nederland.
“Ovarian Cancer Screening”. Lecture for registrars in Medical Oncology London, Royal College of Radiologists, 9th January 2002, Engeland.
“Assessing malignant potential of an adnexal mass”. North-East Thames Gynaecology Meeting, University College Hospital, London, 14th June 2002, Engeland.
“Management of early-stage cervical cancer”. North-East Thames trainees in Obstetrics and Gynaecology, Royal London Hospital, London, 22 November 2002, Engeland.
“Novel molecular diagnostic approaches to identify genetic events in ovarian cancer”. Free University Amsterdam, 29 March, 2001, Nederland.
“Metastasis and Angiogenesis”. Panel member. Helene Harris Memorial Trust: 8th Biennial International Forum on ovarian cancer. MD Anderson Cancer Centre, Houston, USA, 20 March 2001, United States.
“Molecular diagnosis and staging”. Annual British Gynaecological Cancer Society Meeting, London, 14 November 2001, Engeland.
“Molecular Technology in Gynaecological Cancer”. Chairman of workshop. Annual British Gynaecological Cancer Society Meeting, London, 15 November 2001, Engeland.
“Molecular events in angiogenesis/lymphangiogenesis”. ICRF Medical Oncology Seminars, London, 31 January 2001, Engeland.
“Detection of micrometastases by means of molecular biology”. University of Innsbruck (Prof. Ch. Marth), Austria, January 2000, Oostenrijk.
“Molecular Staging in Cervical Cancer”. The VIII Meeting of the International Gynaecologic Cancer Society at Buenos Aires (Argentina), October 22-26, 2000, Argentinië.
“Novel Diagnostic Approaches to Cervical and Ovarian Cancer”. Workshop: “Molecular Biology: any good news?” Buenos Aires (Argentina), October 26, 2000, Argentinië.
“Angiogenesis and Micrometastases in Cervical Cancer”. Grand Round, Barts and the London NHS Trust, March 7, 2000, Engeland.
“Imaging of an adnexal mass”. Academic meeting of Obstetrics and Gynaecology, London, April 14, 2000, Engeland.
“Molecular quantification of micrometastases”. 1st workshop in molecular genetics of cancer, St. Bartholomew’s Hospital, London, May 30, 2000, Engeland.
“Tumour Angiogenesis and Micrometastasis”, Research Scientist Forum, Queen Mary and Westfield College, London, 3rd October, 2000, Engeland.
“The genetics of angiogenesis – A computer based 3D model”. William Harvey Day, Queen Mary University London, 17 October 2000, London, Engeland.
“Molecular staging of cervical cancer using real-time RT-PCR: correlation between number of cancer cells in normal lymph nodes and prognostic features”. The 31st Society of Gynaecologic Oncology Meeting, San Diego, USA, February 4-8, 2000, United States.
“Molecular profiling of angiogenesis and occult micrometastases in cervical cancer”. The British Cancer Research Meeting, Brighton, July 10-12, 2000, Engeland.
“Molecular Staging in Cervical Cancer”. The VIII Meeting of the International Gynecologic Cancer Society at Buenos Aires (Argentina), October 22-26, 2000, Argentinië.
“Tumour Markers, MRI, Radioimmunoscintigraphy, ultrasound and doppler in the differential diagnosis of benign and malignant adnexal masses”. Academic meeting of Gynaecological Oncology, January 8, 1999, Royal London Hospital, Engeland.
“Molecular Staging of Gynaecological Cancer”. Association of North Thames (East) Obstetricians & Gynaecologists, Annual Meeting London, November 19, 1999, Engeland.
“Molecular detection of submicroscopic disease”. Oncology Workshop, Erlangen University, Germany, November 1999, Duitsland.
“Molecular detection of metastatic disease in gynaecological cancer using quantitative RT-PCR for cytokeratin 19”. Selected for oral presentation at the 11th International Meeting of the European Society of Gynaecological Oncology at Budapest (Hungary), 8-12 May 1999, Hongarije.
“Real-time quantitative reverse transcriptase-polymerase chain reaction for the detection of occult micrometastases in cervical cancer patients”. Selected for oral presentation at the 7th Biennial Meeting of the International Gynaecologic Cancer Society at Vatican City (Italy), September 26-30, 1999 and at the Beatson International Cancer Conference “Invasion and Metastasis”, Glasgow, June 26-29, 1999, Schotland.
“Molecular staging in cervical cancer using real-time quantitative RT-PCR: how many cancer cells in the lymph nodes are needed to become clinically significant”. The British Gynaecological Cancer Society meeting in London, November, 1999, Engeland.
“Cytoskeletal aberrations as predictors of invasion in gynaecological cancers”. Royal London Hospital on 29th April 1998 (Queen Mary and Westfield College), London, Engeland.
“Haptoglobin-phenotype: incidentie en klinisch verloop van preeclampsie”. Internationaal Symposium van de NVOG en de VVOG, 1997, Nederland.
“Resultaten van de Bhonsale – vaginoplasty: een retrospectieve studie”. Jaarlijkse vergadering van de Vereniging voor Fertiliteitsstudie van Vlaanderen en Nederland, Corsendonck, 1996, België.
“Estrogen receptor incidence in ductal carcinoma in-situ: estimated benefit following anti-estrogen therapy”. Scientific meeting of the Belgian Association for Cancer Research, 1996: Breast Cancer – Advances and controversies, België.
“Suspicious microcalcifications in the breast: correlation with histopathology”. Advanced course of Breast Cancer, at the European School of Oncology, Milan, Italy, 1995, Italië.
“Endometriose van de blaas”. Nationaal Kongres van de Koninklijke Belgische Vereniging voor Gynaecologie en Verloskunde, Brussel, 1994, België.
“Acute leversteatose in de zwangerschap”. Nationaal Kongres van de Koninklijke Belgische Vereniging voor Gynaecologie en Verloskunde, Brussel, 1993, België.
2022-heden Academic Committee Member Society of European Robotic Gynaecological Surgeons (SERGS)
2017-2021 Council Member Society of European Robotic Gynaecological Surgeons (SERGS)
2016-2019 Voorzitter BIG Pelviene Oncologie VVOG (Pelvic Oncology Group Flemish Organisation VVOG)
2013-2016 Secretaris werkgroep gynaecologische oncologie VVOG
2010-heden Gynaecoloog/Oncoloog en Diensthoofd Gynaecologie/Oncologie AZ Sint-Jan Brugge AV, België
2009-2010 Senior Consultant (Overläkare) Surgeon Gynaecologie/Oncologie in Karolinska University Hospital, Stockholm, Zweden
2007-2009 Gynaecoloog/Oncoloog in AZ Jan Palfijn Ziekenhuis Gent, coördinatie Gynaecologisch Oncologisch Centrum en Borstkliniek, België
2006-2007 Gewoon Hoogleraar (Professor) en Hoofd Gynaecologie & Gynaecologische Oncologie, Academisch Ziekenhuis Maastricht, Nederland
2005-2006 Consultant en Clinical Senior Lecturer (Associate-Professor) Gynaecologische Oncologie, Gynaecological Cancer Centre, St. Bartholomew’s Hospital, London, Engeland
2001-2004 Senior Fellow Gynaecologische Oncologie (“Royal College of Obstetricians and Gynaecologists”), St. Bartholomew’s Hospital & The Royal Marsden Hospital – London (Prof. John Shepherd and Prof. Ian Jacobs); Fellow darmchirurgie, Royal London Hospital (Prof. Sina Dorudi) & Old Church Hospital (Romford; Mr. Clive Hepworth), Engeland
2002-2004 Cancer Research UK Clinician Scientist, Translational Oncology Laboratory, St. Bartholomew’s Hospital, London, Engeland
1998-2001 Clinical Research Fellow (PhD), Gynaecological Oncology Unit (Prof. Ian Jacobs), St. Bartholomew’s Hospital, London, Engeland
1992-1997 Specialist in opleiding in Verloskunde, Gynaecologie en Infertiliteit, Universitair Ziekenhuis Gent, België en St. Elisabeth Ziekenhuis Tilburg, Nederland
1990-1991 Vertegenwoordiger medische studenten België voor het “Erasmus project”
1989-1990 Praeses medische studentenorganisatie Gent (VKG), België
1988-1989 Vice-Praeses medische studentenorganisatie Gent (VKG), België
2015-heden European Society of European Robotic Gynaecological Surgeons (SERGS)
1999-heden European Society of Gynaecological Oncology (ESGO)
2006-heden International Gynaecological Cancer Society (IGCS)
1997-heden Vlaamse Vereniging voor Obstetrie en Gynaecologie (VVOG)
2005-heden Faculty Member of Faculty of 1000 Medicine: Gynaecological Cancer Group
http://www.f1000medicine.com
2010-heden Academia: independent.academia.edu/PhilippeVanTrappen
Yasnaia Bruneel, Christophe Ghysel, Caroline Van Holsbeke, Philippe Van Trappen, Fluorescence guidance during robotic resection of bladder wall endometriosis: case report and technique, Journal of Surgical Case Reports, Volume 2023, Issue 10, October 2023, rjad604, https://doi.org/10.1093/jscr/rjad604
Van Trappen P. Robotic para-aortic sentinel lymph node mapping in endometrial, cervical, and ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 2023 Aug 10;90:102402. doi: 10.1016/j.bpobgyn.2023.102402.
Lebbe I, De Cuypere E, Claes N, Loccufier A, Ghysel C, Van Trappen P. Primary leiomyosarcoma of the uterine cervix: an unusual case and critical appraisal. J Surg Case Rep. 2023 Aug 4;2023(8):rjad439. doi: 10.1093/jscr/rjad439.
Van Trappen P, Lebbe I, De Cuypere E, Claes N. Case report: a robotic-vaginal approach for total vaginectomy and hysterectomy with pelvic sentinel lymph node dissection in primary vaginal melanoma: a 10-step technique and literature review. Front Surg. 2023 May 26;10:1189196. doi: 10.3389/fsurg.2023.1189196.
Van Trappen P, de Cuypere E, Claes N. Robotic surgery in early and advanced ovarian cancer: Case selection for surgical staging and interval debulking surgery. Eur J Obstet Gynecol Reprod Biol. 2023 Jan;280:7-11. doi: 10.1016/j.ejogrb.2022.11.005.
Van Trappen P, De Cuypere E, Claes N, Roels S. Robotic Staging of Cervical Cancer With Simultaneous Detection of Primary Pelvic and Secondary Para-Aortic Sentinel Lymph Nodes: Reproducibility in a First Case Series. Front Surg. 2022 Jun 16;9:905083. doi: 10.3389/fsurg.2022.905083. PMID: 35784928; PMCID: PMC9244622.
Van Trappen P. Indocyanine green guidance for combined robotic pelvic and para-aortic sentinel node mapping in cervical cancer. Surg Oncol. 2022 May;41:101745. doi: 10.1016/j.suronc.2022.101745. Epub 2022 Mar 26. PMID: 35358912.
Delrue C, Vanwalleghem L, Paepe P, Van Trappen P. Stratified Mucin-producing Intraepithelial Lesions of the Cervix: Clinical Diversity of Cases and Literature Review. Anticancer Res. 2022 Feb;42(2):1175-1180. doi: 10.21873/anticanres.15583. PMID: 35093923.
Dumont S, Van Trappen P. The clinical and financial impact of introducing robotic-assisted hysterectomy in a tertiary referral centre: A direct cost analysis of consecutive hysterectomies during a decade. Int J Med Robot. 2021 Oct 16:e2343. doi: 10.1002/rcs.2343. Epub ahead of print. PMID: 34655461.
de Bruyn A, Peeters F, Smulders K, Goffin F, Traen K, Van Trappen P, Vergote I. Observational BGOG Study of the Results of Robot-assisted Laparoscopy in 166 Patients with FIGO 2009 Stage IA1-IB1 Cervical Cancer. J Minim Invasive Gynecol. 2021 Nov;28(11):1920-1926. doi: 10.1016/j.jmig.2021.05.001. Epub 2021 May 14. PMID: 34000393.
Kakkos A, Ver Eecke C, Ongaro S, Traen K, Peeters F, Van Trappen P, Laenen A, Despierre E, Van Nieuwenhuysen E, Vergote I, Goffin F. Robot-assisted surgery for women with endometrial cancer: Surgical and oncologic outcomes within a Belgium gynaecological oncology group cohort. Eur J Surg Oncol. 2021 May;47(5):1117-1123. doi: 10.1016/j.ejso.2020.10.005. Epub 2020 Oct 13. PMID: 33268212.
Persyn B, Van Trappen P. Robotic Hysterectomy Using a Sealing Device: Differences In Complications and Pain Scores Between Small and Large Uteri. Surg Technol Int. 2020 Jun 10;37:sti37/1309. Online ahead of print. PMID: 32520389. https://pubmed.ncbi.nlm.nih.gov/32520389/
Vlaamse Vereniging voor Obstetrie en Gynaecologie (VVOG): “Aanbevelingen bij diagnose en behandeling van cervix carcinoom.” Ph. Van Trappen, namens de VWOG en BIG Pelviene Oncologie 2016-2019. Gunaïkeia, 2020.
Bénédicte Persyn, Philippe Van Trappen. Leverkapselruptuur bij normotensief HELLP-syndroom. Gunaïkeia Vol 24 nr 5, 2019.
Vergote I, Magrina JF, Zanagnolo V, Magtibay PM, Butler K, Gil-Moreno A, Feijoo BD, Kimmig R, Canis M, Bourdel N, Ind T, Estape R, Persson J, Lim P, Coronado P, Ponce J, Lambaudie E, Van Gorp T, Maggioni A, Narducci F, Van Niewwenhuysen E, Van Trappen P. The LACC Trial and Minimally Invasive Surgery in Cervical Cancer. J Minim Invasive Gynecol. 2020 Feb;27(2):462-463. doi: 10.1016/j.jmig.2019.09.767. Epub 2019 Sep 11.
Martin Rudnicki, Philippe van Trappen, Paul van Kesteren. Hysterectomy-Should All Residents Learn to Perform It? Editorial Acta Obstet Gynecol Scand. 2019 Jan;98(1):5-6. doi: 10.1111/aogs.13507.
Rudnicki M, Van Trappen P, van Kesteren P. Hysterectomy-Who should be trained to do it? Acta Obstet Gynecol Scand. 2019 Jun;98(6):814. doi: 10.1111/aogs.13571.
Maggen C, Van Huysse J, Van Trappen P. Simple Vaginal Trachelectomy for Small Volume Cervical Cancer: Case Report and Review of the Literature. EC Gynaecology 5.3(2017):83-90.
Neutens S, Van Trappen P. Eerste Robotgeassisteerde Fertiliteitsparende Baarmoederhalskankeroperatie in Vlaanderen. AZ Link (Sint-Jan Brugge) 35:7-9, 2017.
Coryn N, Serkei E, Weyers S, Van Trappen P. De pil Anno 2016: welke keuze en waarom? Tijdschr. voor Geneeskunde, 72, nr 18, 2016.
Hoste G, Van Trappen P. Robotic hysterectomy using the Vessel Sealer for myomatous uteri: technique and clinical outcome. Eur J Obstet Gynecol Reprod Biol. 2015 Sep 30;194:241-244.
Segaert A, Traen K, Van Trappen P, Peeters F, Leunen K, Goffin F, Vergote I. Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience. Int J Gynecol Cancer. 2015 Nov;25(9):1690-6.
Sap K, Van Trappen Ph. Paradigm shift in the management of gynaecological cancers. EMJ Oncol 2015;3:12–8.
P. Van Trappen. Centralisatie door regionalisatie van gynaecologische kankerzorg: Europees model? Gunaikeia, Vol 20;3:29-33,2015.
De Greve T, Vanwalleghem L, Van Hoof A, Coenegrachts K, Van Trappen P. An unusual cervical tumor as presentation of a non-hodgkin lymphoma. Case Rep Obstet Gynecol. 2014;2014:549619.
Mehra G, Weekes A, Vantrappen P, Visvanathan D, Jeyarajah A. Laparoscopic assisted radical vaginal hysterectomy for cervical carcinoma: morbidity and long-term follow-up. Eur J Surg Oncol. 2010 Mar;36(3):304-8.
Kruse AJ, Bottenberg MJ, Tosserams J, Slangen B, van Marion AM, van Trappen PO. The absence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to the HPV-independent pathway as the causative agent for vulvar squamous cell carcinoma and its precursor simplex VIN in a young patient. Int J Gynecol Pathol. 2008 Oct;27(4):591-5.
S Bishara, M Griffin, A Cargill, A Bali, ME Gore, SB Kaye, JH Shepherd, PO Van Trappen.Pre-treatment white blood cell subtypes as prognostic indicators in ovarian cancer. Eur J Obstet Gynecol. 138:71-75, 2008.
PO Van Trappen, B Rufford, TD Mills, SA Sohaib, JAW Webb, A Sahdev, N Ali, MJ Carroll, KE Britton, RH Reznek, IJ Jacobs. Differential diagnosis of adnexal masses: risk of malignancy index, ultrasonography, MR imaging and radioimmunoscintigraphy. Int J Gynecol Cancer, 17:61-67, 2007.
T Hagemann, T Bozanovic, S Hooper, A Ljubic, VIF Slettenaar, JL Wilson, N Singh, SA Gayther, JH Shepherd, PO Van Trappen. Molecular profiling of primary cervical cancers, lymph node micrometastases and recurrent tumours. Br J Cancer, 96: 321-328, 2007.
PO Van Trappen, T Cullup, R Troke, S Gayther, D Swann, C Mein. Somatic mitochondrial DNA mutations and polymorphisms in primary and metastatic ovarian cancer. Gynecol Oncol, 104: 129-133, 2007.
J Balega, PO Van Trappen. The sentinel lymph node in gynaecological malignancy. Cancer Imaging, 28(6): 7-15, 2006.
PO Van Trappen and MS Pepper. Lymphangiogenesis in female reproductive cancers. Angiogenesis, 8(2): 137-145, 2005.
SA Sohaib, TD Mills, A Sahdev, JA Webb, PO Van Trappen, I Jacobs and RH Reznek. The role of MRI in patients with adnexal masses identified on ultrasound. J Clin Radiol, 60: 340-348, 2005.
T. Bozanovic and PO Van Trappen. Gynaecological cancer and genetics. Cervical cancer and genetics. Gynaecology Forum, 10(1): 24-27, 2005.
A Bali, A Weekes, P Van Trappen, A Jeyarajah, D Querleu. Central pelvic recurrence seven years after radical vaginal trachelectomy. Gynecol Oncol, 96: 854-856, 2005.
PO Van Trappen, D Steele, DG Lowe, S Baithun, P Levey, N Beasley, J Krishnan, JH Shepherd, MS Pepper, D Jackson, JP Sleeman, IJ Jacobs. Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during the different stages of cervical carcinogenesis. J Pathol, 201: 544-554, 2003.
G Zhu, L Reynolds, T Crnogorac-Jurcevic, CE Gillett, EA Dublin, JF Marshall, D Barnes, C D’Arrigo, PO Van Trappen, NR Lemoine and IR Hart. Combination Of Microdissection And Microarray Analysis To Identify Gene Expression Changes Between Differentially Located Tumor Cells In Breast Cancer. Oncogene, 22: 3742-3748, 2003.
SAA Sohaib, A Sahdev, PO Van Trappen, I Jacobs, RH Reznek. Characterisation of adnexal mass lesions on magnetic resonance imaging. Am J Radiol, 180: 1297-1304, 2003.
EC Kohn, IJ Fidler, D Fishman, R Jaffe, LA Liotta, P Van Trappen, GB Mills, C Trope. Discussion: Metastasis and angiogenesis in epithelial ovarian cancer. Gynecol Oncol, 88: S37-S42, 2003.
N Ali, H Jan, PO Van Trappen, F Nasreen, A Canizales, MJ Carroll, M Granowska, IJ Jacobs, KE Britton. Tc-99m SM3 radioimmunoscintigraphy (RIS) and its distinction between malignant and benign adnexal masses. Br J Obstet Gynaecol, 110: 508-514, 2003.
PO Van Trappen and MS Pepper. Lymphatic dissemination of tumour cells and the formation of tumour micrometastases. Lancet Oncol, 3: 44-52, 2002.
Beasley NJP, Prevo R, Banerji S, Leek R, Moore J, Van Trappen PO, Cox G, Harris AL, Jackson DG. Intratumoural lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res, 62: 1315-1320, 2002.
PO Van Trappen, A Ryan, M Carroll, C Lecoeur, L Goff, V Gyselman, B Young, D Lowe, MS Pepper, JH Shepherd, I Jacobs. A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer. Br J Cancer, 87: 537-544, 2002.
Van Trappen PO, Gyselman VG, Lowe DG, Ryan A, Oram DH, Bosze P, Weekes AR, Shepherd JH, Dorudi S, Bustin SA, Jacobs IJ. Molecular quantification and mapping of lymph node micrometastases in cervical cancer. The Lancet, 357: 15-20, 2001.
PO Van Trappen, MS Pepper. Lymphangiogenesis and lymph node microdissemination. Gynecol Oncol, 82: 1-3, 2001.
P. Van Trappen, R. Serreyn, A. E. Elewaut, V. Cocquyt, S. Van Belle. Abdominal pain with anorexia in patients with breast carcinoma. Ann Oncol, 9: 1243-1245, 1998.
P. Van Trappen. Screening and Diagnosis of Gynaecological Cancers: pre-operative assessment of the adnexal mass. The Diplomate (RCOG), 5(3): 208-214, 1998.
P. Van Trappen, K. Verbeken, M. Temmerman. Pre-eclampsia and chromosomal anomalies. J Obstet Gynaecol, 18(6): 550-552, 1998.
P. Van Trappen, P. De Sutter, M. Dhont. Vaginoplasty by inverted perineal and labia minora flaps – a retrospective study. J Obstet Gynaecol, 17(4): 379-382, 1997.
I. Buytaert, A. Elewaut, P. Van Trappen. Liver diseases in pregnancy. Belgian J Medecine, 52 (3): 213-216, 1996.
P. Van Trappen, R. Serreyn, C. De Potter. Estrogen receptor incidence in ductal carcinoma in-situ: estimated benefit following anti-estrogen therapy. Acta Clinica Belgica, 51(3): 205, 1996.
P. Van Trappen, R. Van den Broecke, H. Depypere, C. De Potter, R. Serreyn. Histopathology of microcalcifications in the breast and immunohistochemistry of ductal carcinoma in-situ lesions. Acta Clinica Belgica, 51(3): 207, 1996.
F.M. Belpaire, P. Wynant, P. Van Trappen, M. Dhont, A. Verstraete, M.G. Bogaert. Protein binding of propranolol and verapamil enantiomers in maternal and foetal serum. Br J Clin. Pharmac, 39: 190-193, 1995.
Hoofdstukken
PO Van Trappen, I Jacobs. Controversies and new trends in staging ovarian and fallopian tube carcinoma. Chapter 20. CME J Gynecol Oncol. 6: 260-266, 2001.
PO Van Trappen and IJ Jacobs. The genetics and molecular biology of gynaecological cancer. Gynaecology, Chapter 36: 527-543. Editors: R Shaw, WP Soutter, SL Stanton, 3rd Edition, 2003.
CD-ROM
Van Trappen P. Real-time quantitative reverse transcriptase-polymerase chain reaction for the detection of occult micrometastases in cervical cancer patients. Interactive CD-ROM of Gynaecological Oncology with 40 selected international speakers, IGCS, 1999.
21/10/2023: Invited Video-guided Lecture “Robotic-vaginal en bloc hysterectomy and total vaginectomy for early-stage vaginal melanoma” at the 2nd Annual Congress of the Society of Korean Robot Gynecologic Surgery, South-Korea.
04/10/2023: Invited Lecture “How to perform a successful Robotic Radical Hysterectomy for cervical cancer” at the European Society of Gynaecological Endoscopy (ESGE) Congress, Brussels.
03/10/2023: Organizer and Moderator Live Robotic Surgery at AZ Sint-Jan Hospital Bruges, robotic myomectomy and robotic sacrocolpopexy, for the European Society of Gynaecological Endoscopy (ESGE) Congress in Brussels.
09/06/2023: “Robotic para-aortic staging: who is eligible?” at the Society of European Robotic Gynaecological Surgeons (SERGS) in Athens
16/12/2022: Live Robotic GYN Surgery 4Health – Worldwide Robotic Surgery Events (WRSE12) –
16th December 2022 – International Faculty member – Semi-Live robotic surgery:
Video-recorded surgery
12/11/2022:
Hamburg Intensiv Seminar GYN-ONKO (1200 participants) – 12th November 2022 –
Lecture: “Robotic surgery in Gynecological Oncology: present and future”.
29/10/2022:
European Society of Gynecological Oncology (ESGO) Conference – Berlin – 29th
October Satellite Symposium Intuitive – Lecture: “Use of advanced energy in
pelvic and paraaortic lymph node dissection”.
3/10/2022:
European Society of Gynecological Endoscopy (ESGE) Conference – Lisbon – 3rd
October Satellite Symposium Intuitive – “Meet the professors” session: Lecture
“The value of da Vinci technology in endometrial cancer surgery”.
11/05/2022:
GYN CONNECT Robotics Forum Intuitive – Paris – 11th May 2022 – Lecturer.
6-8/4/2022:
Advanced Course in Robotic Gynaecological Oncology Surgery – joint ESGO-SERGS
(Society of European Robotic Gynecological Surgeons) course – ORSI Belgium –
6-8 April 2022. Master Proctor and Lecturer.
16-17/3/2022:
Peer-to-Peer Master Proctors Robotic Surgery – GYN Summit Intuitive Surgical –
IRCAD Strasbourg – 16-17 March 2022: Lecturer to Peers.
19/10/2021: Webinar European Society for Robotic Gynaecological Surgery (SERGS) – presentation “Robotic complex benign hysterectomy”, P. Van Trappen.
10/06/2021: Gyn Connect Up – International Forum (Intuitive Surgical Inc): presentation “Use of advanced robotic technologies for malignant procedures”, P. Van Trappen
17/3/2020: 1st Webinar SERGS: “Robotic vs Laparoscopic Surgery in Endometriosis”. P. Van Trappen.
7/02/2020: Voordracht voor de Wetenschappelijke Vereniging voor Verzekeringsgeneeskunde (WVV) aan Universiteit Antwerpen: “Chirurg en Robot: een nieuw onafscheidelijk duo”.
26-28/9/2019: 11th Annual SERGS (European Society of Robotic Gynaecological Surgery) meeting in Sofia (Bulgaria): Chairing the session on “Benign Robotic Surgery”; Panel member + presentation on “Endometriosis and Robotics”.
26-28/6/2019: Secondary Advanced Robotic Surgery Course in Gynaecological Oncology – Ghent (Melle) organised by ESGO-SERGS/Faculty members: T. Hebert (France), H. Falconer (Sweden), E. Lambaudie (France), P. Van Trappen (Belgium).
10-11/4/2019: Master Class + Live Surgery voor Robot chirurgie te Berlijn: “Robotic Surgery in Cervical Cancer”– Vivantes Klinikum – Berlin
11 mei 2019: Nationaal congres “Medische Wereld” te Brussel – VUB: “Medisch expert – Fonds voor Medische Ongevallen: efficiënte interactie?”
18 en 19 april 2018: Master Class + Live Surgery voor Robot chirurgie te Berlijn: “Robotic Surgery in Cervical Cancer” – Vivantes Klinikum – Berlin
VVOG congres 04/10/2018 te Mechelen: “Lokaal gevorderd cervix carcinoom”
27-28/09/2018 10th Annual SERGS meeting: Chairing Robot Benigne Gynaecology; Voordracht: Robotic surgery in large uterus
Voorzitter/organisator: Cursus Pelviene Oncologie voor assistenten VVOG, Gent, 20 oktober 2017.
Master Class Chirurgie Robotique, invited speaker: “Place des technologies avancées en chirurgie robotique”. Rennes (Bretagne), France, 13-14 oktober 2017.
Robot chirurgie in gynaecologische oncologie. Oncologie Symposium, De Valckaert, Oostkamp, 11 februari 2017.
Surgical Video day: Robotic radical hysterectomy and Robotic Para-aortic lymph node dissection. 7th Annual British and Irish Association of Robotic Gynaecological Surgeons (BIARGS), University of Leicester (UK), 1-3 maart 2017.
Robotic hysterectomy for a large uterus. 7th Annual British and Irish Association of Robotic Gynaecological Surgeons (BIARGS), University of Leicester (UK), 1-3 maart 2017.
Paradigm shift from laparoscopic to robotic surgery. 7th Annual British and Irish Association of Robotic Gynaecological Surgeons (BIARGS), University of Leicester (UK), 1-3 maart 2017.
Robot chirurgie in gynaecologie/oncologie. Navormingscursus operatieverpleegkundigen, VIVES Hogeschool, Brugge, 7 maart 2017.
Nieuwe Technieken voor behandeling van gynaecologische kankers. Vereniging “Actueel denken en leven”, Kinepolis Brugge, 1 maart 2016.
Robotic Devices – Video debate. 8th Annual Meeting on Robotic Gynaecological Surgery (SERGS), Barcelona (Spanje), 16-18 juni 2016.
Step-by-step Large Uterus Hysterectomy. 8th Annual Meeting on Robotic Gynaecological Surgery (SERGS), Barcelona (Spanje), 16-18 juni 2016.
Robotic surgery in Gynaecology/oncology in Bruges. ESM Intuitive Surgical, Barcelona (Spanje), 25 augustus 2016.
Chairman “New Frontiers in Gynaecological Cancer Management”, Gynaecologisch Oncologisch symposium, Concertgebouw Brugge, 1 oktober 2016.
“Ultra-radical surgery for ovarian cancer” at Royal Marsden Symposium on Surgical Aspects of Ovarian Cancer in London, 9 december 2011, Engeland.
“Bipolar Vessel Sealing Device in Gynaecologische/Oncologische Chirurgie”, voor de Apothekersvereniging van oost-en West-Vlaanderen, 20 oktober 2011, De Pinte, België.
“Endoscopic versus open surgery in endometrial cancer: outcomes” at International Symposium of Gynaecologic Surgery: from benign to cancer – State of the art, Cefalu (Sicily), 27 mei 2011, Italië.
“Primaire en intervaldebulkingchirurgie bij ovariumcarcinoom: state-of-the-art. KHBO Permanante vorming ‘Operatieverpleegkunde’. Brugge, 22 februari 2011.
“Gynaecologische Oncologische Chirurgie: de grenzen verleggen”. AZ Colloquia St.-Jan Brugge. 21 december 2010 en Permanente vorming 2011 Verpleegkundigen heelkunde – operatiekwartier – campus Brugge, 5 apil 2011.
“Chirurgie van vergevorderd ovarium carcinoom”. LOK 0317 – WGSV in Zeeland, 25 september 2010.
“Nieuwe perspectieven in de gynaecologische oncologie”. Voordracht voor artsengroep “Houtland” te Torhout, 14 oktober 2010.
“Surgical treatment of ovarian cancer” at regional doctors meeting Stockholm-Gotland, at Elite Palace Hotel, Stockholm (Sweden) 11 december 2009.
“Surgical treatment of Breast Cancer: what … and why”. Breast Cancer Symposium (Breast Clinic: FAQ) at ’t Pand Ghent, from AZ Jan Palfijn Hospital Ghent, Belgium, 25 April 2009.
“Gynaecologische tumoren: internationale richtlijnen en nieuwe perspectieven.”. Symposium Oncologie – AZ Jan Palfijn 7 juni 2008.
“Technics en Genetics bij cervix, ovarium en mammacarcinoom”. HAVRA huisartsengroep, Aalter, 31 januari 2008, België.
“Vaccinatie ter preventie van het cervix carcinoom”, Randwijck cursus, azM, Maastricht, 27 maart 2007, Nederland.
“De toegevoegde waarde van MRI in de risk of malignancy index. Keynote Lecture voor de gynaecologische oncologie op Doelen Congres Obstetrie/Gynaecologie & Infertiliteit te Rotterdam, 19 april 2007, Nederland.
“Oncologische chirurgie en Robot chirurgie in de gynaecologie”. Lok vergadering Aalst, 30 oktober 2007, België.
“Technics en Genetics bij cervix, ovarium en mammacarcinoom”. Huisartsenvereniging Hippoliet van Peene, Eeklo, 8 november 2007, België.
“Laparoscopie in de gynaecologische oncologie”, Veldhoven refereeravond, 14 november 2006, Nederland.
“From bench to bedside in gynaecological oncology”. VVOG, Overijse (Belgium), 1st October 2005, België.
“Management of early-stage cervical cancer”. North-East Thames specialist registrars meeting. Lecture at The Royal London Hospital, on the 9th January 2004, Engeland.
“Lymphangiogenesis and lymph node metastases”. 13th Meeting of the European Society of Gynaecological Oncology, Brussels, 8th April 2003, België.
“Molecular events in cervical cancer”. University Charles of Prague. Department of Obstetrics & Gynaecology (Prof. Lukas Rob), 19th May 2004, Prague, Czech Republic.
“Progress in Gynaecological Cancer Research”, Karolinska Institute – Stockholm, Sweden. Department of Gynaecological Oncology (Prof. E.A. Lundquist), on 14th June 2004, Zweden.
“Molecular Determinants of Cervical Cancer Progression”. 7th International Conference on Anti-cancer Research. Corfu, Greece. 25-30 October 2004, Griekenland.
“Cervical Cancer Screening”. Joint London course in Oncology. Lecture at Royal College of Radiologists, on the 11th December 2003, Engeland.
“Angiogenesis and Lymphangiogenesis in Gynaecological Cancers”. Dutch Society of Gynaecological Oncology/COBRA; “Metastatic tumours and recurrences”. Utrecht, 12-13th December 2002, Nederland.
“Ovarian Cancer Screening”. Lecture for registrars in Medical Oncology London, Royal College of Radiologists, 9th January 2002, Engeland.
“Assessing malignant potential of an adnexal mass”. North-East Thames Gynaecology Meeting, University College Hospital, London, 14th June 2002, Engeland.
“Management of early-stage cervical cancer”. North-East Thames trainees in Obstetrics and Gynaecology, Royal London Hospital, London, 22 November 2002, Engeland.
“Novel molecular diagnostic approaches to identify genetic events in ovarian cancer”. Free University Amsterdam, 29 March, 2001, Nederland.
“Metastasis and Angiogenesis”. Panel member. Helene Harris Memorial Trust: 8th Biennial International Forum on ovarian cancer. MD Anderson Cancer Centre, Houston, USA, 20 March 2001, United States.
“Molecular diagnosis and staging”. Annual British Gynaecological Cancer Society Meeting, London, 14 November 2001, Engeland.
“Molecular Technology in Gynaecological Cancer”. Chairman of workshop. Annual British Gynaecological Cancer Society Meeting, London, 15 November 2001, Engeland.
“Molecular events in angiogenesis/lymphangiogenesis”. ICRF Medical Oncology Seminars, London, 31 January 2001, Engeland.
“Detection of micrometastases by means of molecular biology”. University of Innsbruck (Prof. Ch. Marth), Austria, January 2000, Oostenrijk.
“Molecular Staging in Cervical Cancer”. The VIII Meeting of the International Gynaecologic Cancer Society at Buenos Aires (Argentina), October 22-26, 2000, Argentinië.
“Novel Diagnostic Approaches to Cervical and Ovarian Cancer”. Workshop: “Molecular Biology: any good news?” Buenos Aires (Argentina), October 26, 2000, Argentinië.
“Angiogenesis and Micrometastases in Cervical Cancer”. Grand Round, Barts and the London NHS Trust, March 7, 2000, Engeland.
“Imaging of an adnexal mass”. Academic meeting of Obstetrics and Gynaecology, London, April 14, 2000, Engeland.
“Molecular quantification of micrometastases”. 1st workshop in molecular genetics of cancer, St. Bartholomew’s Hospital, London, May 30, 2000, Engeland.
“Tumour Angiogenesis and Micrometastasis”, Research Scientist Forum, Queen Mary and Westfield College, London, 3rd October, 2000, Engeland.
“The genetics of angiogenesis – A computer based 3D model”. William Harvey Day, Queen Mary University London, 17 October 2000, London, Engeland.
“Molecular staging of cervical cancer using real-time RT-PCR: correlation between number of cancer cells in normal lymph nodes and prognostic features”. The 31st Society of Gynaecologic Oncology Meeting, San Diego, USA, February 4-8, 2000, United States.
“Molecular profiling of angiogenesis and occult micrometastases in cervical cancer”. The British Cancer Research Meeting, Brighton, July 10-12, 2000, Engeland.
“Molecular Staging in Cervical Cancer”. The VIII Meeting of the International Gynecologic Cancer Society at Buenos Aires (Argentina), October 22-26, 2000, Argentinië.
“Tumour Markers, MRI, Radioimmunoscintigraphy, ultrasound and doppler in the differential diagnosis of benign and malignant adnexal masses”. Academic meeting of Gynaecological Oncology, January 8, 1999, Royal London Hospital, Engeland.
“Molecular Staging of Gynaecological Cancer”. Association of North Thames (East) Obstetricians & Gynaecologists, Annual Meeting London, November 19, 1999, Engeland.
“Molecular detection of submicroscopic disease”. Oncology Workshop, Erlangen University, Germany, November 1999, Duitsland.
“Molecular detection of metastatic disease in gynaecological cancer using quantitative RT-PCR for cytokeratin 19”. Selected for oral presentation at the 11th International Meeting of the European Society of Gynaecological Oncology at Budapest (Hungary), 8-12 May 1999, Hongarije.
“Real-time quantitative reverse transcriptase-polymerase chain reaction for the detection of occult micrometastases in cervical cancer patients”. Selected for oral presentation at the 7th Biennial Meeting of the International Gynaecologic Cancer Society at Vatican City (Italy), September 26-30, 1999 and at the Beatson International Cancer Conference “Invasion and Metastasis”, Glasgow, June 26-29, 1999, Schotland.
“Molecular staging in cervical cancer using real-time quantitative RT-PCR: how many cancer cells in the lymph nodes are needed to become clinically significant”. The British Gynaecological Cancer Society meeting in London, November, 1999, Engeland.
“Cytoskeletal aberrations as predictors of invasion in gynaecological cancers”. Royal London Hospital on 29th April 1998 (Queen Mary and Westfield College), London, Engeland.
“Haptoglobin-phenotype: incidentie en klinisch verloop van preeclampsie”. Internationaal Symposium van de NVOG en de VVOG, 1997, Nederland.
“Resultaten van de Bhonsale – vaginoplasty: een retrospectieve studie”. Jaarlijkse vergadering van de Vereniging voor Fertiliteitsstudie van Vlaanderen en Nederland, Corsendonck, 1996, België.
“Estrogen receptor incidence in ductal carcinoma in-situ: estimated benefit following anti-estrogen therapy”. Scientific meeting of the Belgian Association for Cancer Research, 1996: Breast Cancer – Advances and controversies, België.
“Suspicious microcalcifications in the breast: correlation with histopathology”. Advanced course of Breast Cancer, at the European School of Oncology, Milan, Italy, 1995, Italië.
“Endometriose van de blaas”. Nationaal Kongres van de Koninklijke Belgische Vereniging voor Gynaecologie en Verloskunde, Brussel, 1994, België.
“Acute leversteatose in de zwangerschap”. Nationaal Kongres van de Koninklijke Belgische Vereniging voor Gynaecologie en Verloskunde, Brussel, 1993, België.
2022-heden Academic Committee Member Society of European Robotic Gynaecological Surgeons (SERGS)
2017-2021 Council Member Society of European Robotic Gynaecological Surgeons (SERGS)
2016-2019 Voorzitter BIG Pelviene Oncologie VVOG (Pelvic Oncology Group Flemish Organisation VVOG)
2013-2016 Secretaris werkgroep gynaecologische oncologie VVOG
2010-heden Gynaecoloog/Oncoloog en Diensthoofd Gynaecologie/Oncologie AZ Sint-Jan Brugge AV, België
2009-2010 Senior Consultant (Overläkare) Surgeon Gynaecologie/Oncologie in Karolinska University Hospital, Stockholm, Zweden
2007-2009 Gynaecoloog/Oncoloog in AZ Jan Palfijn Ziekenhuis Gent, coördinatie Gynaecologisch Oncologisch Centrum en Borstkliniek, België
2006-2007 Gewoon Hoogleraar (Professor) en Hoofd Gynaecologie & Gynaecologische Oncologie, Academisch Ziekenhuis Maastricht, Nederland
2005-2006 Consultant en Clinical Senior Lecturer (Associate-Professor) Gynaecologische Oncologie, Gynaecological Cancer Centre, St. Bartholomew’s Hospital, London, Engeland
2001-2004 Senior Fellow Gynaecologische Oncologie (“Royal College of Obstetricians and Gynaecologists”), St. Bartholomew’s Hospital & The Royal Marsden Hospital – London (Prof. John Shepherd and Prof. Ian Jacobs); Fellow darmchirurgie, Royal London Hospital (Prof. Sina Dorudi) & Old Church Hospital (Romford; Mr. Clive Hepworth), Engeland
2002-2004 Cancer Research UK Clinician Scientist, Translational Oncology Laboratory, St. Bartholomew’s Hospital, London, Engeland
1998-2001 Clinical Research Fellow (PhD), Gynaecological Oncology Unit (Prof. Ian Jacobs), St. Bartholomew’s Hospital, London, Engeland
1992-1997 Specialist in opleiding in Verloskunde, Gynaecologie en Infertiliteit, Universitair Ziekenhuis Gent, België en St. Elisabeth Ziekenhuis Tilburg, Nederland
1990-1991 Vertegenwoordiger medische studenten België voor het “Erasmus project”
1989-1990 Praeses medische studentenorganisatie Gent (VKG), België
1988-1989 Vice-Praeses medische studentenorganisatie Gent (VKG), België
2015-heden European Society of European Robotic Gynaecological Surgeons (SERGS)
1999-heden European Society of Gynaecological Oncology (ESGO)
2006-heden International Gynaecological Cancer Society (IGCS)
1997-heden Vlaamse Vereniging voor Obstetrie en Gynaecologie (VVOG)
2005-heden Faculty Member of Faculty of 1000 Medicine: Gynaecological Cancer Group
http://www.f1000medicine.com
2010-heden Academia: independent.academia.edu/PhilippeVanTrappen
